isovaleric acid - Ontology Report - Rat Genome Database

Submit Data | Help | Video Tutorials | News | Publications | Download | REST API | Citing RGD | Contact

Advanced Search (OLGA)

CHEBI ONTOLOGY - ANNOTATIONS

{{ watchLinkText }}

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:	isovaleric acid	go back to main search page
Accession:	CHEBI:28484	browse the term
Definition:	A C5, branched-chain saturated fatty acid.
Synonyms:	related_synonym:	3-Methylbutanoic acid; 3-Methylbuttersaeure; 3-methyl-n-butyric acid; 3-methylbutyric acid; Formula=C5H10O2; InChI=1S/C5H10O2/c1-4(2)3-5(6)7/h4H,3H2,1-2H3,(H,6,7); InChIKey=GWYFCOCPABKNJV-UHFFFAOYSA-N; Isovalerate; Isovaleriansaeure; SMILES=CC(C)CC(O)=O; beta-methylbutyric acid; delphinic acid; isobutylformic acid; isopentanoic acid; isopropylacetic acid; isovalerianic acid
	alt_id:	CHEBI:24930; CHEBI:43426; CHEBI:6069
	xref:	Beilstein:1098522; CAS:503-74-2; DrugBank:DB03750; Gmelin:101117; KEGG:C08262; KNApSAcK:C00001189; LIPID_MAPS_instance:LMFA01020181
	xref_mesh:	MESH:C008216
	xref:	PDBeChem:IVA; PMID:12743728; PPDB:3129
	cyclic_relationship:	is_conjugate_acid_of CHEBI:48942

show annotations for term's descendants Sort by:
Rat (1715) Mouse (1678) Human (1683) Chinchilla (0) Bonobo (0) Dog (0) Squirrel (0) Pig (0) Green Monkey (0) Naked Mole-rat (0) All
Genes (1715)

isovaleric acid

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

leptin receptor

affects abundance

LEPR affects the abundance of isovaleric acid

NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908

G

UDP glucuronosyltransferase 1 family, polypeptide A2

increases glucuronidation

UGT1A3 protein results in increased glucuronidation of isovaleric acid analog

NCBI chr 9:88,791,216...88,808,465
Ensembl chr 9:88,713,184...88,808,465

3-hydroxyisovaleric acid

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

AKT serine/threonine kinase 1

multiple interactions

[Dexamethasone co-treated with beta-hydroxyisovaleric acid] results in increased phosphorylation of AKT1 protein

NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921

G

F-box protein 32

increases expression
multiple interactions

beta-hydroxyisovaleric acid results in increased expression of FBXO32 mRNA
beta-hydroxyisovaleric acid inhibits the reaction [Dexamethasone results in increased expression of FBXO32 mRNA]

NCBI chr 7:89,731,428...89,764,997
Ensembl chr 7:89,730,232...89,765,436

G

ubiquitin specific peptidase 16

increases expression

beta-hydroxyisovaleric acid results in increased expression of USP16 mRNA

NCBI chr11:26,681,359...26,711,313
Ensembl chr11:26,681,414...26,710,539

G

ubiquitin specific peptidase 2

increases expression

beta-hydroxyisovaleric acid results in increased expression of USP2 mRNA

NCBI chr 8:44,411,457...44,439,668
Ensembl chr 8:44,411,607...44,438,331

G

ubiquitin specific peptidase 28

increases expression

beta-hydroxyisovaleric acid results in increased expression of USP28 mRNA

NCBI chr 8:49,325,766...49,386,229
Ensembl chr 8:49,325,867...49,386,229

fenvalerate

term browser

Symbol

Object Name

Qualifiers

Evidence

Notes

Source

PubMed Reference(s)

RGD Reference(s)

Position

G

alpha-2-macroglobulin

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of A2M protein

NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786

G

alpha 1,3-galactosyltransferase 2

increases expression

fenvalerate results in increased expression of A3GALT2 mRNA

NCBI chr 5:141,101,329...141,113,760
Ensembl chr 5:141,107,983...141,115,641

G

AP2 associated kinase 1

increases expression

fenvalerate results in increased expression of AAK1 mRNA

NCBI chr 4:119,300,128...119,451,834
Ensembl chr 4:119,295,257...119,450,969

G

ATP binding cassette subfamily B member 1A

multiple interactions
decreases activity
decreases expression

fenvalerate inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]
fenvalerate results in decreased activity of ABCB1 protein
fenvalerate results in decreased expression of ABCB1A mRNA

PMID:21783720 PMID:30307764

NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709

G

ATP binding cassette subfamily B member 6

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ABCB6 protein

NCBI chr 9:76,668,554...76,677,263
Ensembl chr 9:76,668,554...76,676,924

G

ATP binding cassette subfamily G member 1

increases expression

fenvalerate results in increased expression of ABCG1 mRNA

NCBI chr20:9,126,687...9,182,948
Ensembl chr20:9,126,687...9,182,948

G

ATP binding cassette subfamily G member 4

increases expression

fenvalerate results in increased expression of ABCG4 mRNA

NCBI chr 8:44,611,187...44,629,818
Ensembl chr 8:44,611,187...44,626,881

G

ATP binding cassette subfamily G member 5

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ABCG5 protein

NCBI chr 6:9,965,118...9,990,563
Ensembl chr 6:9,965,118...9,990,563

G

ABHD11 antisense RNA 1 (tail to tail)

increases expression

fenvalerate results in increased expression of BICDL3P mRNA

NCBI chr12:21,681,118...21,682,106

G

abhydrolase domain containing 8

increases expression

fenvalerate results in increased expression of ABHD8 mRNA

NCBI chr16:18,144,464...18,151,201
Ensembl chr16:18,144,464...18,157,667

G

histo-blood group ABO system transferase 3

increases expression

fenvalerate results in increased expression of ABO3 mRNA

NCBI chr 3:9,743,861...9,761,049
Ensembl chr 3:9,646,515...9,761,043

G

ABR activator of RhoGEF and GTPase

increases expression

fenvalerate results in increased expression of ABR mRNA

NCBI chr10:61,262,516...61,461,331
Ensembl chr10:61,262,516...61,461,505

G

acetyl-CoA acetyltransferase 2

decreases expression

fenvalerate results in decreased expression of ACAT2 protein

NCBI chr 1:47,695,833...47,713,879
Ensembl chr 1:47,695,788...47,752,821

G

acyl-CoA binding domain containing 4

increases expression

fenvalerate results in increased expression of ACBD4 mRNA

NCBI chr10:88,048,058...88,062,612
Ensembl chr10:88,048,108...88,058,500

G

angiotensin I converting enzyme

affects methylation

fenvalerate affects the methylation of ACE gene

NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131

G

acetylcholinesterase

multiple interactions
affects activity
decreases activity
increases activity

[cypermethrin co-treated with fenvalerate] results in decreased activity of ACHE protein
fenvalerate affects the activity of ACHE protein
fenvalerate results in decreased activity of ACHE protein
fenvalerate results in increased activity of ACHE protein

PMID:8385837 PMID:10355540 PMID:15186033

NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651

G

atypical chemokine receptor 3

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ACKR3 protein

NCBI chr 9:90,799,682...90,811,246
Ensembl chr 9:90,799,686...90,811,237

G

acyl-CoA oxidase 1

increases activity

fenvalerate metabolite results in increased activity of ACOX1 protein

NCBI chr10:101,406,197...101,431,252
Ensembl chr10:101,406,197...101,431,232

G

acyl-CoA synthetase bubblegum family member 2

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ACSBG2 protein

NCBI chr 9:1,683,846...1,715,517
Ensembl chr 9:1,683,847...1,714,518

G

acyl-CoA synthetase long-chain family member 1

increases expression

fenvalerate results in increased expression of ACSL1 mRNA

NCBI chr16:45,755,246...45,821,541
Ensembl chr16:45,755,254...45,821,541

G

actinin, alpha 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ACTN1 protein

NCBI chr 6:98,998,553...99,093,334
Ensembl chr 6:98,998,556...99,093,251

G

activin A receptor type 1C

increases expression

fenvalerate results in increased expression of ACVR1C mRNA

NCBI chr 3:42,815,490...42,892,423
Ensembl chr 3:42,822,610...42,892,327

G

ADAM metallopeptidase domain 2

increases expression

fenvalerate results in increased expression of ADAM2 mRNA

NCBI chr15:40,242,651...40,284,025
Ensembl chr15:40,242,783...40,283,952

G

ADAM metallopeptidase domain 22

increases expression

fenvalerate results in increased expression of ADAM22 mRNA

NCBI chr 4:25,716,055...25,970,932
Ensembl chr 4:25,715,990...25,964,962

G

ADAM metallopeptidase domain 23

increases expression

fenvalerate results in increased expression of ADAM23 mRNA

NCBI chr 9:64,862,649...65,009,718
Ensembl chr 9:64,862,878...65,006,515

G

ADAM metallopeptidase domain 7

increases expression

fenvalerate results in increased expression of ADAM7 mRNA

NCBI chr15:42,833,796...42,882,201
Ensembl chr15:42,833,796...42,882,201

G

ADAM metallopeptidase domain 8

increases expression

fenvalerate results in increased expression of ADAM8 mRNA

NCBI chr 1:194,776,559...194,789,330
Ensembl chr 1:194,770,060...194,788,801

G

ADAM metallopeptidase with thrombospondin type 1 motif, 7

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of ADAMTS7 protein

NCBI chr 8:90,704,727...90,744,333
Ensembl chr 8:90,704,727...90,744,328

G

adenosine deaminase, RNA-specific, B1

decreases expression

fenvalerate results in decreased expression of ADARB1 mRNA

NCBI chr20:11,222,569...11,350,854
Ensembl chr20:11,222,583...11,350,852

G

adenylate cyclase 2

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ADCY2 protein

NCBI chr 1:34,375,639...34,822,252
Ensembl chr 1:34,375,895...34,822,236

G

adenylate cyclase 4

increases expression

fenvalerate results in increased expression of ADCY4 mRNA

NCBI chr15:29,266,280...29,282,153
Ensembl chr15:29,266,287...29,282,108

G

ADCYAP receptor type I

increases expression

fenvalerate results in increased expression of ADCYAP1R1 mRNA

NCBI chr 4:84,593,558...84,642,700
Ensembl chr 4:84,593,892...84,642,700

G

adducin 1

increases expression
multiple interactions

fenvalerate results in increased expression of ADD1 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ADD1 protein

PMID:30307764 PMID:34896426

NCBI chr14:76,108,643...76,167,267
Ensembl chr14:76,108,654...76,167,182

G

adhesion G protein-coupled receptor B3

increases expression

fenvalerate results in increased expression of ADGRB3 mRNA

NCBI chr 9:27,421,168...28,148,979
Ensembl chr 9:27,421,168...28,148,855

G

adhesion G protein-coupled receptor G6

increases expression

fenvalerate results in increased expression of ADGRG6 mRNA

NCBI chr 1:8,812,889...8,954,239
Ensembl chr 1:8,812,904...8,954,123

G

adhesion G protein-coupled receptor L3

increases expression

fenvalerate results in increased expression of ADGRL3 mRNA

NCBI chr14:26,336,320...27,104,060
Ensembl chr14:26,368,277...27,105,860

G

adenosine A1 receptor

decreases expression

fenvalerate results in decreased expression of ADORA1 mRNA

NCBI chr13:45,658,872...45,695,821
Ensembl chr13:45,658,872...45,695,801

G

adrenoceptor beta 3

increases expression

fenvalerate results in increased expression of ADRB3 mRNA

NCBI chr16:64,839,820...64,844,552
Ensembl chr16:64,841,788...64,844,552

G

adenylosuccinate synthase 2

increases expression

fenvalerate results in increased expression of ADSS2 mRNA

NCBI chr13:89,769,240...89,799,577
Ensembl chr13:89,769,244...89,799,604

G

AE binding protein 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of AEBP1 protein

NCBI chr14:80,738,800...80,748,878
Ensembl chr14:80,738,892...80,748,877

G

afadin, adherens junction formation factor

increases expression

fenvalerate results in increased expression of AFDN mRNA

NCBI chr 1:53,905,344...54,034,216
Ensembl chr 1:53,905,373...54,034,216

G

amylo-alpha-1,6-glucosidase and 4-alpha-glucanotransferase

increases expression

fenvalerate results in increased expression of AGL mRNA

NCBI chr 2:204,705,053...204,760,966
Ensembl chr 2:204,705,053...204,760,828

G

1-acylglycerol-3-phosphate O-acyltransferase 3

increases expression

fenvalerate results in increased expression of AGPAT3 mRNA

NCBI chr20:10,330,960...10,415,358
Ensembl chr20:10,384,507...10,415,358

G

ATP/GTP binding carboxypeptidase 1

increases expression

fenvalerate results in increased expression of AGTPBP1 mRNA

NCBI chr17:5,120,540...5,238,874
Ensembl chr17:5,120,609...5,238,869

G

alanine-glyoxylate aminotransferase 2

increases expression

fenvalerate results in increased expression of AGXT2 mRNA

NCBI chr 2:59,336,252...59,377,664
Ensembl chr 2:59,336,283...59,377,926

G

allograft inflammatory factor 1-like

increases expression

fenvalerate results in increased expression of AIF1L mRNA

NCBI chr 3:15,229,476...15,254,033
Ensembl chr 3:15,229,524...15,254,023

G

apical junction component 1 homolog

increases expression

fenvalerate results in increased expression of AJM1 mRNA

NCBI chr 3:8,394,942...8,401,323
Ensembl chr 3:8,392,889...8,401,321

G

adenylate kinase 2

decreases expression

fenvalerate results in decreased expression of AK2 protein

NCBI chr 5:141,308,650...141,364,633
Ensembl chr 5:141,346,063...141,364,632

G

adenylate kinase 3

increases expression

fenvalerate results in increased expression of AK3 protein

NCBI chr 1:226,737,472...226,764,647
Ensembl chr 1:226,739,318...226,764,625

G

adenylate kinase 5

increases expression

fenvalerate results in increased expression of AK5 mRNA

NCBI chr 2:241,397,297...241,581,483
Ensembl chr 2:241,397,297...241,581,458

G

adenylate kinase 7

decreases expression

fenvalerate results in decreased expression of AK7 mRNA

NCBI chr 6:124,611,789...124,679,978
Ensembl chr 6:124,611,902...124,679,961

G

A-kinase anchoring protein 1

increases expression

fenvalerate results in increased expression of AKAP1 mRNA

NCBI chr10:73,621,021...73,654,123
Ensembl chr10:73,621,883...73,653,896

G

A-kinase anchoring protein 13

increases expression

fenvalerate results in increased expression of AKAP13 mRNA

NCBI chr 1:129,313,183...129,619,647
Ensembl chr 1:129,314,402...129,619,646

G

A-kinase anchoring protein 14

increases expression

fenvalerate results in increased expression of AKAP14 mRNA

NCBI chr X:116,395,512...116,410,697
Ensembl chr X:116,395,516...116,410,697

G

A-kinase anchoring protein 3

increases expression

fenvalerate results in increased expression of AKAP3 mRNA

NCBI chr 4:159,688,049...159,714,067
Ensembl chr 4:159,699,289...159,713,903

G

A-kinase anchoring protein 5

decreases expression

fenvalerate results in decreased expression of AKAP5 mRNA

NCBI chr 6:95,051,527...95,061,075
Ensembl chr 6:95,051,537...95,061,578

G

A-kinase anchoring protein 7

increases expression

fenvalerate results in increased expression of AKAP7 mRNA

NCBI chr 1:20,087,190...20,217,799
Ensembl chr 1:20,087,373...20,217,797

G

AKT serine/threonine kinase 1

multiple interactions
increases phosphorylation

[[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with fenvalerate] results in increased phosphorylation of AKT1 protein
fenvalerate results in increased phosphorylation of AKT1 protein

NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921

G

AKT serine/threonine kinase 3

increases expression

fenvalerate results in increased expression of AKT3 mRNA

NCBI chr13:88,943,708...89,225,831
Ensembl chr13:88,946,091...89,225,708

G

albumin

decreases expression

fenvalerate results in decreased expression of ALB protein

NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836

G

aldehyde dehydrogenase 6 family, member A1

increases expression

fenvalerate results in increased expression of ALDH6A1 mRNA

NCBI chr 6:104,077,975...104,098,636
Ensembl chr 6:104,077,979...104,098,656

G

aldolase, fructose-bisphosphate A

decreases expression

fenvalerate results in decreased expression of ALDOA protein

NCBI chr 1:181,402,275...181,407,476
Ensembl chr 1:181,402,275...181,406,182

G

arachidonate 15-lipoxygenase

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ALOX15 protein

NCBI chr10:55,060,169...55,068,885
Ensembl chr10:55,060,412...55,068,874

G

alpha-kinase 3

increases expression

fenvalerate results in increased expression of ALPK3 mRNA

NCBI chr 1:135,014,455...135,062,294
Ensembl chr 1:135,014,499...135,062,302

G

alkaline phosphatase, biomineralization associated

multiple interactions
increases activity

fenvalerate inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA]; fenvalerate inhibits the reaction [Progesterone results in increased activity of ALPL protein]
fenvalerate results in increased activity of ALPL protein

PMID:15696646 PMID:16326432 PMID:29149346

NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446

G

ALX homeobox 3

increases expression

fenvalerate results in increased expression of ALX3 mRNA

NCBI chr 2:195,231,197...195,241,609
Ensembl chr 2:195,231,197...195,241,609

G

amelogenin, X-linked

increases expression

fenvalerate results in increased expression of AMELX mRNA

NCBI chr X:25,076,362...25,087,660
Ensembl chr X:25,076,362...25,087,660

G

anti-Mullerian hormone

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of AMH mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of AMH mRNA

PMID:34896426 PMID:36053783

NCBI chr 7:8,906,776...8,909,192
Ensembl chr 7:8,906,836...8,909,282

G

antagonist of mitotic exit network 1 homolog

increases expression

fenvalerate results in increased expression of AMN1 mRNA

NCBI chr 4:182,155,140...182,182,085
Ensembl chr 4:182,155,142...182,182,016

G

androgen regulated protein

increases expression

fenvalerate results in increased expression of ANDPRO mRNA

NCBI chr 3:136,718,601...136,725,131
Ensembl chr 3:136,718,602...136,724,966

G

ankyrin 2

increases expression

fenvalerate results in increased expression of ANK2 mRNA

NCBI chr 2:215,378,028...215,954,015
Ensembl chr 2:215,379,680...215,862,923

G

ankyrin repeat and EF-hand domain containing 1

increases expression

fenvalerate results in increased expression of ANKEF1 mRNA

NCBI chr 3:123,847,832...123,883,060
Ensembl chr 3:123,847,817...123,883,059

G

ANKH inorganic pyrophosphate transport regulator

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ANKH protein

NCBI chr 2:78,153,027...78,280,181
Ensembl chr 2:78,153,026...78,280,187

G

ankyrin repeat and IBR domain containing 1

increases expression

fenvalerate results in increased expression of ANKIB1 mRNA

NCBI chr 4:30,333,678...30,457,781
Ensembl chr 4:30,333,677...30,457,781

G

ankyrin repeat domain 1

increases expression

fenvalerate results in increased expression of ANKRD1 mRNA

NCBI chr 1:233,815,851...233,834,891
Ensembl chr 1:233,815,851...233,834,919

G

ankyrin repeat domain 52

increases expression

fenvalerate results in increased expression of ANKRD52 mRNA

NCBI chr 7:806,829...820,481
Ensembl chr 7:806,767...820,481

G

ankyrin repeat domain 6

increases expression

fenvalerate results in increased expression of ANKRD6 mRNA

NCBI chr 5:47,197,981...47,343,183
Ensembl chr 5:47,202,873...47,343,090

G

ankyrin repeat domain 60

increases expression

fenvalerate results in increased expression of ANKRD60 mRNA

NCBI chr 3:162,365,158...162,376,491
Ensembl chr 3:162,364,896...162,375,596

G

ankyrin repeat domain 63

increases expression

fenvalerate results in increased expression of ANKRD63 mRNA

NCBI chr 3:105,675,148...105,679,970
Ensembl chr 3:105,663,638...105,682,404

G

ankyrin repeat domain 9

decreases expression

fenvalerate results in decreased expression of ANKRD9 mRNA

NCBI chr 6:130,001,914...130,008,792
Ensembl chr 6:129,998,486...130,008,923

G

anoctamin 3

increases expression

fenvalerate results in increased expression of ANO3 mRNA

NCBI chr 3:97,235,671...97,550,090
Ensembl chr 3:97,238,354...97,550,154

G

anoctamin 8

increases expression

fenvalerate results in increased expression of ANO8 mRNA

NCBI chr16:18,163,853...18,173,248
Ensembl chr16:18,163,843...18,173,545

G

anoctamin 9

increases expression

fenvalerate results in increased expression of ANO9 mRNA

NCBI chr 1:196,208,863...196,230,381
Ensembl chr 1:196,197,341...196,229,900

G

ANTXR cell adhesion molecule 1

increases expression

fenvalerate results in increased expression of ANTXR1 mRNA

NCBI chr 4:119,590,770...119,778,232
Ensembl chr 4:119,590,771...119,778,232

G

annexin A6

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ANXA6 protein

NCBI chr10:39,101,395...39,156,483
Ensembl chr10:39,097,109...39,156,433

G

apolipoprotein D

increases expression

fenvalerate results in increased expression of APOD mRNA

NCBI chr11:69,431,261...69,452,306
Ensembl chr11:69,431,260...69,452,305

G

apolipoprotein E

increases expression

fenvalerate results in increased expression of APOE mRNA

NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932

G

apolipoprotein L11a

increases expression

fenvalerate results in increased expression of APOL11A mRNA

NCBI chr 7:109,248,260...109,262,266
Ensembl chr 7:109,248,942...109,253,716

G

androgen receptor

multiple interactions
decreases activity
increases expression

[Dihydrotestosterone co-treated with fenvalerate] results in decreased expression of AR mRNA; Dihydrotestosterone inhibits the reaction [fenvalerate results in increased activity of AR protein]; fenvalerate inhibits the reaction [Dihydrotestosterone binds to and results in increased activity of AR protein]
fenvalerate results in decreased activity of AR protein
fenvalerate results in increased expression of AR protein
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of AR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of AR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of AR mRNA

PMID:15064155 PMID:16125883 PMID:16857237 PMID:20410157 PMID:21232584 More...

NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925

G

ADP-ribosylation factor 2

increases expression

fenvalerate results in increased expression of ARF2 mRNA

NCBI chr10:88,867,836...88,889,654
Ensembl chr10:88,867,836...88,889,659

G

arginase 2

increases expression

fenvalerate results in increased expression of ARG2 mRNA

NCBI chr 6:97,936,002...97,961,379
Ensembl chr 6:97,936,002...97,961,378

G

Rho GTPase activating protein 10

increases expression

fenvalerate results in increased expression of ARHGAP10 mRNA

NCBI chr19:30,448,572...30,710,315
Ensembl chr19:30,448,637...30,710,313

G

Rho guanine nucleotide exchange factor 28

increases expression

fenvalerate results in increased expression of ARHGEF28 mRNA

NCBI chr 2:29,263,888...29,560,595
Ensembl chr 2:29,263,886...29,560,672

G

AT-rich interaction domain 3B

increases expression

fenvalerate results in increased expression of ARID3B mRNA

NCBI chr 8:58,193,268...58,240,901
Ensembl chr 8:58,193,418...58,238,318

G

ariadne RBR E3 ubiquitin protein ligase 1

increases expression

fenvalerate results in increased expression of ARIH1 mRNA

NCBI chr 8:59,777,378...59,879,762
Ensembl chr 8:59,777,379...59,880,245

G

arkadia C-terminal like ring finger ubiquitin ligase 2C

increases expression

fenvalerate results in increased expression of ARK2C mRNA

NCBI chr18:70,984,566...71,100,836
Ensembl chr18:70,989,731...71,100,836

G

ARF like GTPase 5C

increases expression

fenvalerate results in increased expression of ARL5C mRNA

NCBI chr10:82,985,213...82,993,425
Ensembl chr10:82,985,216...82,992,002

G

ARF like GTPase 8B

increases expression

fenvalerate results in increased expression of ARL8B mRNA

NCBI chr 4:141,748,634...141,792,605
Ensembl chr 4:141,748,587...141,792,596

G

ARF like GTPase 9

increases expression

fenvalerate results in increased expression of ARL9 mRNA

NCBI chr14:31,157,573...31,166,803
Ensembl chr14:31,157,586...31,166,699

G

armadillo repeat containing 5

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ARMC5 protein

NCBI chr 1:182,820,141...182,826,913
Ensembl chr 1:182,820,141...182,826,907

G

armadillo-like helical domain containing 4

increases expression

fenvalerate results in increased expression of ARMH4 mRNA

NCBI chr15:22,975,895...23,076,986
Ensembl chr15:22,975,895...23,076,949

G

aryl hydrocarbon receptor nuclear translocator 2

increases expression

fenvalerate results in increased expression of ARNT2 mRNA

NCBI chr 1:138,236,235...138,392,868
Ensembl chr 1:138,189,940...138,393,153

G

actin related protein 2/3 complex, subunit 1B

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of ARPC1B protein

NCBI chr12:9,482,176...9,495,772
Ensembl chr12:9,480,831...9,495,747

G

arylsulfatase G

increases expression

fenvalerate results in increased expression of ARSG mRNA

NCBI chr10:94,412,261...94,551,224
Ensembl chr10:94,447,399...94,542,941

G

ADP-ribosyltransferase 1

increases expression

fenvalerate results in increased expression of ART1 mRNA

NCBI chr 1:156,478,096...156,487,172
Ensembl chr 1:156,482,621...156,487,172

G

aristaless related homeobox

increases expression

fenvalerate results in increased expression of ARX mRNA

NCBI chr X:58,016,233...58,028,149
Ensembl chr X:58,016,233...58,028,142

G

acid sensing ion channel subunit 2

increases expression

fenvalerate results in increased expression of ASIC2 mRNA

NCBI chr10:65,870,592...66,940,577
Ensembl chr10:65,870,594...66,940,424

G

acetylserotonin O-methyltransferase

increases expression

fenvalerate results in increased expression of ASMT mRNA

NCBI chr12:16,304,719...16,309,568
Ensembl chr12:16,304,719...16,309,568

G

aspartate beta-hydroxylase domain containing 1

increases expression

fenvalerate results in increased expression of ASPHD1 mRNA

NCBI chr 1:181,552,968...181,556,902
Ensembl chr 1:181,552,884...181,556,090

G

ASPSCR1 tether for SLC2A4, UBX domain containing

increases expression

fenvalerate results in increased expression of ASPSCR1 mRNA

NCBI chr10:105,952,215...105,990,059
Ensembl chr10:105,952,227...105,989,904

G

activating transcription factor 3

increases expression

fenvalerate results in increased expression of ATF3 mRNA

NCBI chr13:102,751,278...102,800,520
Ensembl chr13:102,751,321...102,764,631

G

atrophin 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ATN1 protein

NCBI chr 4:157,554,287...157,568,092
Ensembl chr 4:157,551,276...157,568,132

G

atos homolog A

increases expression

fenvalerate results in increased expression of ATOSA mRNA

NCBI chr 8:75,694,828...75,772,565
Ensembl chr 8:75,695,022...75,772,549

G

ATPase Na+/K+ transporting subunit alpha 4

increases expression

fenvalerate results in increased expression of ATP1A4 mRNA

NCBI chr13:84,683,766...84,719,790
Ensembl chr13:84,683,768...84,719,687

G

ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ATP2A1 protein

NCBI chr 1:181,026,606...181,044,859
Ensembl chr 1:181,026,608...181,044,838

G

ATPase plasma membrane Ca2+ transporting 3

increases expression

fenvalerate results in increased expression of ATP2B3 mRNA

NCBI chr X:151,216,483...151,289,069
Ensembl chr X:151,216,507...151,286,775

G

ATPase plasma membrane Ca2+ transporting 4

increases expression

fenvalerate results in increased expression of ATP2B4 mRNA

NCBI chr13:45,156,137...45,255,292
Ensembl chr13:45,156,146...45,255,246

G

ATPase secretory pathway Ca2+ transporting 1

increases expression

fenvalerate results in increased expression of ATP2C1 mRNA

NCBI chr 8:106,034,777...106,155,854
Ensembl chr 8:106,034,636...106,156,006

G

ATP synthase F1 subunit alpha

decreases expression

fenvalerate results in decreased expression of ATP5F1A protein

NCBI chr18:71,292,406...71,300,342
Ensembl chr18:71,292,374...71,300,794

G

ATPase H+ transporting V0 subunit a4

increases expression

fenvalerate results in increased expression of ATP6V0A4 mRNA

NCBI chr 4:66,760,163...66,842,126
Ensembl chr 4:66,760,159...66,842,110

G

ATPase H+ transporting V1 subunit C2

increases expression

fenvalerate results in increased expression of ATP6V1C2 mRNA

NCBI chr 6:40,080,545...40,144,199
Ensembl chr 6:40,080,547...40,120,028

G

ATPase H+ transporting V1 subunit G3

increases expression

fenvalerate results in increased expression of ATP6V1G3 mRNA

NCBI chr13:49,800,256...49,825,247
Ensembl chr13:49,794,222...49,825,247

G

ATPase phospholipid transporting 8B2

increases expression

fenvalerate results in increased expression of ATP8B2 mRNA

NCBI chr 2:175,378,514...175,402,265
Ensembl chr 2:175,378,517...175,401,883

G

ataxin 1

increases expression

fenvalerate results in increased expression of ATXN1 mRNA

NCBI chr17:18,737,491...19,142,360
Ensembl chr17:18,737,533...19,142,360

G

aurora kinase A and ninein interacting protein

increases expression

fenvalerate results in increased expression of AUNIP mRNA

NCBI chr 5:146,722,329...146,734,924
Ensembl chr 5:146,722,337...146,736,501

G

aurora kinase A

increases expression

fenvalerate results in increased expression of AURKA mRNA

NCBI chr 3:161,128,309...161,144,524
Ensembl chr 3:161,128,313...161,144,390

G

aurora kinase C

increases expression

fenvalerate results in increased expression of AURKC mRNA

NCBI chr 1:66,843,653...66,849,775
Ensembl chr 1:66,843,653...66,864,386

G

activator of transcription and developmental regulator AUTS2

increases expression

fenvalerate results in increased expression of AUTS2 mRNA

NCBI chr12:24,104,187...25,194,123
Ensembl chr12:24,104,192...25,194,416

G

advillin

increases expression
multiple interactions

fenvalerate results in increased expression of AVIL mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of AVIL protein

PMID:30307764 PMID:34896426

NCBI chr 7:62,825,459...62,844,103
Ensembl chr 7:62,826,025...62,844,071

G

UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5

increases expression

fenvalerate results in increased expression of B3GNT5 mRNA

NCBI chr11:81,141,102...81,153,206
Ensembl chr11:81,140,599...81,156,166

G

BAALC binder of MAP3K1 and KLF4

increases expression

fenvalerate results in increased expression of BAALC mRNA

NCBI chr 7:69,918,998...69,992,289
Ensembl chr 7:69,918,998...69,992,288

G

BRISC and BRCA1 A complex member 2

increases expression

fenvalerate results in increased expression of BABAM2 mRNA

NCBI chr 6:24,369,021...24,788,416
Ensembl chr 6:24,369,022...24,833,951

G

brain abundant, membrane attached signal protein 1

increases expression

fenvalerate results in increased expression of BASP1 mRNA

NCBI chr 2:75,816,130...75,863,801
Ensembl chr 2:75,816,122...75,864,043

G

BCL2 associated X, apoptosis regulator

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of BAX mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of BAX mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of BAX mRNA

PMID:33396045 PMID:34896426 PMID:36053783

NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368

G

bromodomain adjacent to zinc finger domain, 1A

increases expression

fenvalerate results in increased expression of BAZ1A mRNA

NCBI chr 6:72,389,701...72,512,516
Ensembl chr 6:72,389,703...72,512,459

G

bromodomain adjacent to zinc finger domain, 1B

increases expression

fenvalerate results in increased expression of BAZ1B mRNA

NCBI chr12:21,431,985...21,489,956
Ensembl chr12:21,431,985...21,490,426

G

Bardet-Biedl syndrome 7

increases expression

fenvalerate results in increased expression of BBS7 mRNA

NCBI chr 2:119,434,760...119,474,665
Ensembl chr 2:119,434,760...119,474,396

G

brevican

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of BCAN protein

NCBI chr 2:173,454,479...173,467,717
Ensembl chr 2:173,454,482...173,467,460

G

BCAS3, microtubule associated cell migration factor

increases expression

fenvalerate results in increased expression of BCAS3 mRNA

NCBI chr10:70,213,710...70,673,080
Ensembl chr10:70,214,098...70,673,080

G

BCL2, apoptosis regulator

multiple interactions

[[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with fenvalerate] results in increased expression of BCL2 protein
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of BCL2 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of BCL2 mRNA

PMID:28949029 PMID:33396045 PMID:34896426 PMID:36053783

NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743
Ensembl chr13:22,684,989...22,853,743

G

Bcl2-like 1

multiple interactions

[[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with fenvalerate] results in increased expression of BCL2L1 protein

NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
Ensembl chr 1:141,253,523...141,303,479

G

bradykinin receptor B2

increases expression

fenvalerate results in increased expression of BDKRB2 mRNA

NCBI chr 6:124,472,317...124,502,497
Ensembl chr 6:124,472,566...124,502,497

G

brain-derived neurotrophic factor

increases expression
decreases expression

fenvalerate results in increased expression of BDNF mRNA
fenvalerate results in decreased expression of BDNF mRNA

PMID:16166269 PMID:34358930

NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615

G

BEN domain containing 4

increases expression

fenvalerate results in increased expression of BEND4 mRNA

NCBI chr14:40,753,048...40,788,686
Ensembl chr14:40,753,077...40,783,504

G

brain expressed X-linked 2

increases expression

fenvalerate results in increased expression of BEX1 mRNA

NCBI chr X:99,019,847...99,021,375
Ensembl chr X:99,019,000...99,021,503

G

beaded filament structural protein 1

increases expression

fenvalerate results in increased expression of BFSP1 mRNA

NCBI chr 3:131,195,087...131,252,668
Ensembl chr 3:131,195,087...131,229,337

G

BH3 interacting domain death agonist

multiple interactions

[[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with fenvalerate] results in decreased expression of BID protein

NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720

G

beta-galactosidase-like protein

increases expression

fenvalerate results in increased expression of BIN2A mRNA

NCBI chr 8:25,248,570...25,287,173
Ensembl chr 8:25,248,570...25,287,173

G

bone morphogenetic protein 6

increases expression

fenvalerate results in increased expression of BMP6 mRNA

NCBI chr17:26,318,121...26,469,691
Ensembl chr17:26,318,569...26,470,365

G

bisphosphoglycerate mutase

decreases expression

fenvalerate results in decreased expression of BPGM protein

NCBI chr 4:63,139,730...63,168,581
Ensembl chr 4:63,140,018...63,168,581

G

BPI fold containing family B, member 2

increases expression

fenvalerate results in increased expression of BPIFB2 mRNA

NCBI chr 3:142,356,990...142,377,053
Ensembl chr 3:142,358,051...142,377,044

G

BRCA1, DNA repair associated

affects binding
increases expression
multiple interactions

fenvalerate binds to BRCA1 protein
fenvalerate results in increased expression of BRCA1 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of BRCA1 protein

PMID:30307764 PMID:32278787 PMID:34896426

NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304

G

bromodomain testis associated

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of BRDT mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of BRDT mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of BRDT mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of BRDT protein

PMID:33051911 PMID:33396045 PMID:34896426

NCBI chr14:2,387,372...2,445,857
Ensembl chr14:2,387,796...2,445,842

G

BRF1 general transcription factor IIIB subunit

decreases expression

fenvalerate results in decreased expression of BRF1 mRNA

NCBI chr 6:132,034,378...132,081,313
Ensembl chr 6:132,037,272...132,081,278

G

BMP/retinoic acid inducible neural specific 2

increases expression

fenvalerate results in increased expression of BRINP2 mRNA

NCBI chr13:70,431,006...70,532,766
Ensembl chr13:70,431,010...70,531,810

G

BMP/retinoic acid inducible neural specific 3

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of BRINP3 protein

NCBI chr13:58,413,883...58,846,828
Ensembl chr13:58,413,883...58,846,770

G

C1q and TNF related 4

increases expression

fenvalerate results in increased expression of C1QTNF4 mRNA

NCBI chr 3:76,854,368...76,872,991
Ensembl chr 3:76,857,735...76,874,139

G

similar to human chromosome 1 open reading frame 52

decreases expression

fenvalerate results in decreased expression of C2H1ORF52 mRNA

NCBI chr 2:234,853,378...234,860,045
Ensembl chr 2:234,853,410...234,860,040

G

complement C3

affects expression
multiple interactions

fenvalerate affects the expression of C3 protein
fenvalerate affects the expression of and results in increased activity of C3 protein

NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429

G

complement C3a receptor 1

increases expression

fenvalerate results in increased expression of C3AR1 mRNA

NCBI chr 4:156,074,747...156,084,680
Ensembl chr 4:156,075,389...156,084,701

G

calcium binding protein, spermatid associated 1

increases expression

fenvalerate results in increased expression of CABS1 mRNA

NCBI chr14:20,096,962...20,099,024
Ensembl chr14:20,096,899...20,099,181

G

calcium voltage-gated channel subunit alpha1 A

increases expression

fenvalerate results in increased expression of CACNA1A mRNA

NCBI chr19:23,520,741...23,819,971
Ensembl chr19:23,520,741...23,823,225

G

calcium voltage-gated channel subunit alpha1 B

increases expression

fenvalerate results in increased expression of CACNA1B mRNA

NCBI chr 3:7,380,892...7,546,104
Ensembl chr 3:7,380,922...7,546,091

G

calcium voltage-gated channel subunit alpha1 C

increases expression
multiple interactions

fenvalerate results in increased expression of CACNA1C mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CACNA1C protein

PMID:30307764 PMID:34896426

NCBI chr 4:151,764,138...152,379,454
Ensembl chr 4:151,764,138...152,379,648

G

calcium voltage-gated channel subunit alpha1 S

increases expression
multiple interactions

fenvalerate results in increased expression of CACNA1S mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CACNA1S protein

PMID:30307764 PMID:34896426

NCBI chr13:47,493,949...47,564,194
Ensembl chr13:47,493,949...47,564,318

G

calcium voltage-gated channel auxiliary subunit alpha2delta 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CACNA2D1 protein

NCBI chr 4:18,950,611...19,374,969
Ensembl chr 4:18,951,002...19,374,969

G

calcium voltage-gated channel auxiliary subunit beta 2

increases expression

fenvalerate results in increased expression of CACNB2 mRNA

NCBI chr17:77,564,630...77,910,000
Ensembl chr17:77,564,460...77,909,106

G

calcium voltage-gated channel auxiliary subunit beta 4

increases expression

fenvalerate results in increased expression of CACNB4 mRNA

NCBI chr 3:36,906,771...37,169,165
Ensembl chr 3:36,910,427...37,168,944

G

calcium voltage-gated channel auxiliary subunit gamma 5

increases expression

fenvalerate results in increased expression of CACNG5 mRNA

NCBI chr10:92,827,441...92,869,632
Ensembl chr10:92,829,196...92,869,614

G

calcium voltage-gated channel auxiliary subunit gamma 7

increases expression

fenvalerate results in increased expression of CACNG7 mRNA

NCBI chr 1:65,800,059...65,831,246
Ensembl chr 1:65,800,355...65,831,006

G

calcitonin-related polypeptide alpha

increases expression

fenvalerate results in increased expression of CALCA mRNA

NCBI chr 1:168,878,212...168,883,176
Ensembl chr 1:168,878,214...168,883,105

G

calcitonin receptor

increases expression

fenvalerate results in increased expression of CALCR mRNA

NCBI chr 4:31,661,270...31,736,392
Ensembl chr 4:31,661,273...31,736,392

G

calcium homeostasis modulator family member 6

increases expression

fenvalerate results in increased expression of CALHM6 mRNA

NCBI chr20:26,095,591...26,097,336
Ensembl chr20:26,095,592...26,097,278

G

calmodulin 1

increases expression

fenvalerate results in increased expression of CALM1 mRNA; fenvalerate results in increased expression of CALM1 protein

NCBI chr 6:119,487,691...119,495,759
Ensembl chr 6:119,487,621...119,498,227

G

calcium/calmodulin-dependent protein kinase IG

increases expression

fenvalerate results in increased expression of CAMK1G mRNA

NCBI chr13:104,877,909...104,901,658
Ensembl chr13:104,877,910...104,901,556

G

calcium/calmodulin-dependent protein kinase kinase 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CAMKK1 protein

NCBI chr10:57,637,335...57,660,498
Ensembl chr10:57,637,391...57,660,498

G

calcium/calmodulin-dependent protein kinase kinase 2

increases expression

fenvalerate results in increased expression of CAMKK2 mRNA

NCBI chr12:33,791,023...33,845,000
Ensembl chr12:33,791,052...33,843,279

G

CaM kinase-like vesicle-associated

increases expression

fenvalerate results in increased expression of CAMKV mRNA

NCBI chr 8:108,626,821...108,641,169
Ensembl chr 8:108,626,821...108,641,169

G

calmodulin regulated spectrin-associated protein 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of CAMSAP1 protein

NCBI chr 3:8,746,176...8,806,067
Ensembl chr 3:8,746,176...8,806,072

G

calpain 10

increases expression

fenvalerate results in increased expression of CAPN10 mRNA

NCBI chr 9:93,498,132...93,510,494
Ensembl chr 9:93,498,478...93,510,494

G

calpain 3

increases expression

fenvalerate results in increased expression of CAPN3 mRNA

NCBI chr 3:107,407,518...107,457,858
Ensembl chr 3:107,407,850...107,457,858

G

calpain 8

increases expression

fenvalerate results in increased expression of CAPN8 mRNA

NCBI chr13:94,252,218...94,316,146
Ensembl chr13:94,253,054...94,316,146

G

cell cycle associated protein 1

increases expression

fenvalerate results in increased expression of CAPRIN1 mRNA

NCBI chr 3:90,152,305...90,230,447
Ensembl chr 3:90,153,620...90,230,502

G

carbonic anhydrase 2

decreases expression

fenvalerate results in decreased expression of CAR2 protein

NCBI chr 2:86,741,625...86,756,766
Ensembl chr 2:86,741,626...86,756,818

G

carbonic anhydrase 6

decreases expression

fenvalerate results in decreased expression of CA6 mRNA

NCBI chr 5:160,658,104...160,676,644
Ensembl chr 5:160,658,105...160,676,644

G

capping protein regulator and myosin 1 linker 3

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CARMIL3 protein

NCBI chr15:28,978,440...28,995,865
Ensembl chr15:28,979,007...28,996,225

G

CASC3 exon junction complex subunit

increases expression

fenvalerate results in increased expression of CASC3 mRNA

NCBI chr10:83,769,014...83,788,966
Ensembl chr10:83,769,001...83,788,966

G

caspase 3

multiple interactions
increases cleavage

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [fenvalerate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased cleavage of CASP3 protein]]; [U 0126 co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] inhibits the reaction [fenvalerate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased cleavage of CASP3 protein]]; fenvalerate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased cleavage of CASP3 protein]; U 0126 promotes the reaction [fenvalerate inhibits the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in increased cleavage of CASP3 protein]]
fenvalerate results in increased cleavage of CASP3 protein
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CASP3 mRNA; CAT protein inhibits the reaction [fenvalerate results in increased cleavage of CASP3 protein]

PMID:28949029 PMID:30307764 PMID:34896426

NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648

G

caspase 9

increases expression
multiple interactions

fenvalerate results in increased expression of CASP9 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CASP9 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CASP9 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of CASP9 mRNA

PMID:30307764 PMID:33396045 PMID:34896426 PMID:36053783

NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626

G

castor zinc finger 1

increases expression

fenvalerate results in increased expression of CASZ1 mRNA

NCBI chr 5:159,243,965...159,393,935
Ensembl chr 5:159,243,995...159,393,400

G

catalase

multiple interactions
decreases activity
increases activity

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the activity of CAT protein; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased activity of CAT protein; [cypermethrin co-treated with fenvalerate] results in increased activity of CAT protein; CAT protein inhibits the reaction [fenvalerate results in increased cleavage of CASP3 protein]; CAT protein inhibits the reaction [fenvalerate results in increased cleavage of PARP1 protein]
fenvalerate metabolite results in decreased activity of CAT protein; fenvalerate results in decreased activity of CAT protein
fenvalerate results in increased activity of CAT protein

PMID:10355540 PMID:15892188 PMID:30307764 PMID:33396045 PMID:35678313

NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478

G

core-binding factor subunit beta

increases expression

fenvalerate results in increased expression of CBFB mRNA

NCBI chr19:33,049,162...33,092,752
Ensembl chr19:33,049,172...33,092,751

G

cobalamin binding intrinsic factor

increases expression

fenvalerate results in increased expression of CBLIF mRNA

NCBI chr 1:208,605,983...208,620,231
Ensembl chr 1:208,605,983...208,620,344

G

cerebellin 1 precursor

increases expression

fenvalerate results in increased expression of CBLN1 mRNA

NCBI chr19:19,608,763...19,612,572
Ensembl chr19:19,608,716...19,612,572

G

coiled-coil and C2 domain containing 1A

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CC2D1A protein

NCBI chr19:24,011,897...24,026,937
Ensembl chr19:24,011,938...24,026,936

G

coiled-coil and C2 domain containing 2A

increases expression

fenvalerate results in increased expression of CC2D2A mRNA

NCBI chr14:67,349,004...67,435,883
Ensembl chr14:67,351,353...67,435,949

G

coiled-coil domain containing 127

increases expression

fenvalerate results in increased expression of CCDC127 mRNA

NCBI chr 1:28,928,420...28,935,885
Ensembl chr 1:28,928,325...28,935,893

G

coiled-coil domain containing 13

increases expression

fenvalerate results in increased expression of CCDC13 mRNA

NCBI chr 8:121,455,202...121,507,487
Ensembl chr 8:121,457,697...121,502,337

G

coiled-coil domain containing 25

increases expression

fenvalerate results in increased expression of CCDC25 mRNA

NCBI chr15:40,055,368...40,087,758
Ensembl chr15:40,055,368...40,087,758

G

coiled-coil domain containing 30

increases expression

fenvalerate results in increased expression of CCDC30 mRNA

NCBI chr 5:132,926,767...133,019,635
Ensembl chr 5:132,926,615...133,019,659

G

coiled-coil domain containing 65

increases expression

fenvalerate results in increased expression of CCDC65 mRNA

NCBI chr 7:129,857,118...129,870,803
Ensembl chr 7:129,857,247...129,870,803

G

cholecystokinin A receptor

increases expression

fenvalerate results in increased expression of CCKAR mRNA

NCBI chr14:57,292,397...57,300,747
Ensembl chr14:57,292,397...57,300,747

G

C-C motif chemokine ligand 2

decreases expression

fenvalerate results in decreased expression of CCL2 mRNA

NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226

G

C-C motif chemokine ligand 3

increases expression

fenvalerate results in increased expression of CCL3 mRNA

NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938

G

C-C motif chemokine ligand 7

increases expression

fenvalerate results in increased expression of CCL7 mRNA

NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,016,446...67,018,303

G

cellular communication network factor 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CCN1 protein

NCBI chr 2:234,562,410...234,565,370
Ensembl chr 2:234,562,408...234,565,484

G

cellular communication network factor 4

increases expression

fenvalerate results in increased expression of CCN4 mRNA

NCBI chr 7:98,645,238...98,677,253
Ensembl chr 7:98,645,182...98,677,248

G

cellular communication network factor 5

increases expression

fenvalerate results in increased expression of CCN5 mRNA

NCBI chr 3:152,491,247...152,502,639
Ensembl chr 3:152,491,220...152,502,636

G

cyclin A2

increases expression

fenvalerate results in increased expression of CCNA2 mRNA

NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577

G

C-C motif chemokine receptor like 2

increases expression

fenvalerate results in increased expression of CCRL2 mRNA

NCBI chr 8:111,034,279...111,036,914
Ensembl chr 8:111,034,279...111,036,664

G

coiled-coil serine-rich protein 2

decreases expression

fenvalerate results in decreased expression of CCSER2 mRNA

NCBI chr16:12,613,103...12,725,764
Ensembl chr16:12,613,103...12,725,738

G

chaperonin containing TCP1 subunit 3

decreases expression

fenvalerate results in decreased expression of CCT3 protein

NCBI chr 2:173,765,701...173,790,353
Ensembl chr 2:173,765,698...173,790,757

G

chaperonin containing TCP1 subunit 8

increases expression

fenvalerate results in increased expression of CCT8 protein

NCBI chr11:26,710,370...26,722,079
Ensembl chr11:26,710,370...26,722,079

G

CD24 molecule

increases expression

fenvalerate results in increased expression of CD24 mRNA

NCBI chr20:47,074,353...47,079,662
Ensembl chr20:47,073,512...47,079,662

G

Cd28 molecule

increases expression

fenvalerate results in increased expression of CD28 mRNA

NCBI chr 9:62,166,324...62,194,674
Ensembl chr 9:62,166,192...62,194,685

G

CD36 molecule

decreases expression

fenvalerate results in decreased expression of CD36 mRNA

NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903

G

CD38 molecule

increases expression

fenvalerate results in increased expression of CD38 mRNA

NCBI chr14:67,172,062...67,212,328
Ensembl chr14:67,172,063...67,211,986

G

CD9 molecule

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of CD9 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CD9 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of CD9 mRNA

PMID:33051911 PMID:33396045 PMID:34896426

NCBI chr 4:158,256,328...158,289,136
Ensembl chr 4:158,256,328...158,289,222

G

cell division cycle 45

increases expression

fenvalerate results in increased expression of CDC45 mRNA

NCBI chr11:82,185,427...82,210,630
Ensembl chr11:82,185,473...82,210,619

G

cadherin 11

increases expression

fenvalerate results in increased expression of CDH11 mRNA

NCBI chr19:2,148,447...2,305,754
Ensembl chr19:2,148,458...2,304,272

G

cadherin 13

increases expression

fenvalerate results in increased expression of CDH13 mRNA

NCBI chr19:46,349,562...47,387,462
Ensembl chr19:46,349,430...47,387,459

G

cadherin 22

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CDH22 protein

NCBI chr 3:153,845,563...153,970,630
Ensembl chr 3:153,845,787...153,970,588

G

cadherin-related 23

increases expression

fenvalerate results in increased expression of CDH23 mRNA

NCBI chr20:28,240,643...28,622,490
Ensembl chr20:28,240,645...28,622,419

G

cyclin-dependent kinase 13

increases expression

fenvalerate results in increased expression of CDK13 mRNA

NCBI chr17:47,251,145...47,344,675
Ensembl chr17:47,251,163...47,341,721

G

cyclin dependent kinase 2

increases expression
multiple interactions
affects binding

fenvalerate results in increased expression of CDK2 mRNA
CDKN1B protein inhibits the reaction [fenvalerate results in increased expression of CDK2 mRNA]
fenvalerate binds to CDK2 protein

PMID:22850687 PMID:32278787

NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403

G

CDK5 regulatory subunit associated protein 2

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CDK5RAP2 protein

NCBI chr 5:83,792,282...83,961,129
Ensembl chr 5:83,792,284...83,960,782

G

cyclin-dependent kinase 6

increases expression

fenvalerate results in increased expression of CDK6 mRNA

NCBI chr 4:30,637,650...30,829,688
Ensembl chr 4:30,646,460...30,829,634

G

cyclin-dependent kinase 9

increases expression

fenvalerate results in increased expression of CDK9 mRNA

NCBI chr 3:15,996,467...16,001,315
Ensembl chr 3:15,996,468...16,002,410

G

cyclin-dependent kinase inhibitor 1A

increases expression

fenvalerate results in increased expression of CDKN1A mRNA

NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585

G

cyclin-dependent kinase inhibitor 1B

multiple interactions
decreases expression
decreases response to substance

CDKN1B protein inhibits the reaction [fenvalerate results in increased expression of CDK2 mRNA]
fenvalerate results in decreased expression of CDKN1B mRNA; fenvalerate results in decreased expression of CDKN1B protein
CDKN1B protein results in decreased susceptibility to fenvalerate

NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982

G

CCAAT/enhancer binding protein epsilon

increases expression

fenvalerate results in increased expression of CEBPE mRNA

NCBI chr15:28,169,711...28,171,471
Ensembl chr15:28,169,704...28,171,814

G

chymotrypsin like elastase 1

decreases expression

fenvalerate results in decreased expression of CELA1 mRNA

NCBI chr 7:131,773,161...131,786,300
Ensembl chr 7:131,742,002...131,786,285

G

CUGBP, Elav-like family member 5

increases expression

fenvalerate results in increased expression of CELF5 mRNA

NCBI chr 7:8,225,787...8,250,322
Ensembl chr 7:8,225,825...8,250,322

G

centromere protein F

decreases expression

fenvalerate results in decreased expression of CENPF protein

NCBI chr13:101,184,127...101,229,714
Ensembl chr13:101,184,127...101,229,669

G

centromere protein T

increases expression

fenvalerate results in increased expression of CENPT mRNA

NCBI chr19:33,734,684...33,741,159
Ensembl chr19:33,734,685...33,741,142

G

centromere protein X

decreases expression

fenvalerate results in decreased expression of CENPX mRNA

NCBI chr10:105,991,469...105,994,310

G

centrosomal protein 126

increases expression

fenvalerate results in increased expression of CEP126 mRNA

NCBI chr 8:5,200,576...5,267,740
Ensembl chr 8:5,218,509...5,267,467

G

centrosomal protein 350

increases expression

fenvalerate results in increased expression of CEP350 mRNA

NCBI chr13:68,023,327...68,164,478
Ensembl chr13:68,026,891...68,165,214

G

centrosomal protein 68

increases expression

fenvalerate results in increased expression of CEP68 mRNA

NCBI chr14:94,447,973...94,470,533
Ensembl chr14:94,449,055...94,470,517

G

centrosomal protein 76

increases expression

fenvalerate results in increased expression of CEP76 mRNA

NCBI chr18:61,174,514...61,208,512
Ensembl chr18:61,178,310...61,208,504

G

CERK like autophagy regulator

increases expression

fenvalerate results in increased expression of CERKL mRNA

NCBI chr 3:64,238,714...64,344,695
Ensembl chr 3:64,237,522...64,340,675

G

carboxylesterase 1D

increases metabolic processing

CES1 protein results in increased metabolism of fenvalerate

NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035

G

carboxylesterase 2E

affects metabolic processing

CES2E protein affects the metabolism of fenvalerate

NCBI chr19:157,447...172,822
Ensembl chr19:157,407...172,856

G

cilia and flagella associated protein 100

increases expression

fenvalerate results in increased expression of CFAP100 mRNA

NCBI chr 4:122,914,693...122,938,994
Ensembl chr 4:122,914,698...122,938,580

G

cilia and flagella associated protein 144

increases expression

fenvalerate results in increased expression of CFAP144 mRNA

NCBI chr10:43,509,823...43,519,693
Ensembl chr10:43,509,826...43,520,086

G

cilia and flagella associated protein 161

decreases expression

fenvalerate results in decreased expression of CFAP161 protein

NCBI chr 1:137,743,783...137,768,685
Ensembl chr 1:137,743,784...137,768,730

G

cilia and flagella associated protein 300

decreases expression

fenvalerate results in decreased expression of CFAP300 protein

NCBI chr 8:5,180,180...5,198,840
Ensembl chr 8:5,180,675...5,198,807

G

complement factor B

decreases expression

fenvalerate results in decreased expression of CFB protein

NCBI chr20:3,970,643...3,976,510
Ensembl chr20:3,951,474...3,976,505

G

craniofacial development protein 1

increases expression

fenvalerate results in increased expression of CFDP1 mRNA

NCBI chr19:39,718,313...39,823,824
Ensembl chr19:39,718,347...39,823,824

G

CF transmembrane conductance regulator

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CFTR protein

NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756

G

chromatin assembly factor 1 subunit B

increases expression

fenvalerate results in increased expression of CHAF1B mRNA

NCBI chr11:33,200,894...33,221,076
Ensembl chr11:33,200,981...33,221,070

G

chromodomain helicase DNA binding protein 7

increases expression

fenvalerate results in increased expression of CHD7 mRNA

NCBI chr 5:21,812,007...21,995,358
Ensembl chr 5:21,812,070...21,995,358

G

checkpoint kinase 2

increases expression

fenvalerate results in increased expression of CHEK2 mRNA

NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286

G

CHM Rab escort protein

increases expression

fenvalerate results in increased expression of CHM mRNA

NCBI chr X:78,203,200...78,361,996
Ensembl chr X:78,203,204...78,361,943

G

cholinergic receptor nicotinic alpha 3 subunit

increases expression

fenvalerate results in increased expression of CHRNA3 mRNA

NCBI chr 8:55,401,668...55,415,165
Ensembl chr 8:55,401,702...55,415,165

G

cholinergic receptor nicotinic alpha 9 subunit

increases expression

fenvalerate results in increased expression of CHRNA9 mRNA

NCBI chr14:42,235,218...42,241,939
Ensembl chr14:42,235,226...42,242,192

G

cholinergic receptor nicotinic beta 1 subunit

increases expression

fenvalerate results in increased expression of CHRNB1 mRNA

NCBI chr10:54,501,096...54,516,418
Ensembl chr10:54,501,093...54,516,345

G

cholinergic receptor nicotinic epsilon subunit

increases expression

fenvalerate results in increased expression of CHRNE mRNA

NCBI chr10:55,331,211...55,339,923
Ensembl chr10:55,331,212...55,335,530

G

class II, major histocompatibility complex, transactivator

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of CIITA mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CIITA mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of CIITA mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of CIITA mRNA

PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783

NCBI chr10:5,139,947...5,187,493
Ensembl chr10:5,140,178...5,187,440

G

ciliary microtubule associated protein 3

increases expression

fenvalerate results in increased expression of CIMAP3 mRNA

NCBI chr 2:193,475,785...193,493,092
Ensembl chr 2:193,475,782...193,493,139

G

cold inducible RNA binding protein

decreases expression

fenvalerate results in decreased expression of CIRBP mRNA

NCBI chr 7:9,533,857...9,538,899
Ensembl chr 7:9,424,178...9,538,818

G

cytokine inducible SH2-containing protein

increases expression

fenvalerate results in increased expression of CISH mRNA

NCBI chr 8:107,972,306...107,977,254
Ensembl chr 8:107,972,306...107,977,250

G

cytoskeleton-associated protein 4

increases expression

fenvalerate results in increased expression of CKAP4 mRNA

NCBI chr 7:19,230,814...19,238,914
Ensembl chr 7:19,230,203...19,238,914

G

CLK4-associating serine/arginine rich protein

increases expression

fenvalerate results in increased expression of CLASRP mRNA

NCBI chr 1:79,232,260...79,256,462
Ensembl chr 1:79,232,261...79,256,354

G

claudin 10

increases expression

fenvalerate results in increased expression of CLDN10 mRNA

NCBI chr15:95,862,785...95,954,526
Ensembl chr15:95,862,760...95,954,526

G

C-type lectin domain containing 16A

decreases expression

fenvalerate results in decreased expression of CLEC16A mRNA

NCBI chr10:4,927,799...5,123,749
Ensembl chr10:4,928,030...5,123,578

G

chloride intracellular channel 4

increases expression

fenvalerate results in increased expression of CLIC4 mRNA

NCBI chr 5:147,453,702...147,513,455
Ensembl chr 5:147,453,712...147,513,452

G

clathrin heavy chain

increases expression

fenvalerate results in increased expression of CLTC mRNA

NCBI chr10:71,517,661...71,574,591
Ensembl chr10:71,517,663...71,573,737

G

clusterin

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of CLU mRNA

NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315

G

chymase 1

increases expression

fenvalerate results in increased expression of CMA1 mRNA

NCBI chr15:29,417,451...29,420,233
Ensembl chr15:29,417,451...29,420,233

G

chemerin chemokine-like receptor 1

increases expression

fenvalerate results in increased expression of CMKLR1 mRNA

NCBI chr12:42,974,462...43,027,321
Ensembl chr12:42,974,410...43,028,129

G

CKLF-like MARVEL transmembrane domain containing 4

increases expression

fenvalerate results in increased expression of CMTM4 mRNA

NCBI chr19:576,203...616,109
Ensembl chr19:576,203...616,109

G

cyclic nucleotide binding domain containing 2

increases expression

fenvalerate results in increased expression of CNBD2 mRNA

NCBI chr 3:144,819,166...144,884,825
Ensembl chr 3:144,819,195...144,901,583

G

cyclic nucleotide gated channel subunit beta 1

increases expression

fenvalerate results in increased expression of CNGB1 mRNA

NCBI chr19:9,726,595...9,791,111
Ensembl chr19:9,726,595...9,791,173

G

chondromodulin

increases expression

fenvalerate results in increased expression of CNMD mRNA

NCBI chr15:55,041,548...55,066,297
Ensembl chr15:55,041,561...55,066,297

G

CCR4-NOT transcription complex, subunit 6

increases expression

fenvalerate results in increased expression of CNOT6 mRNA

NCBI chr10:33,978,785...34,031,025
Ensembl chr10:33,980,831...34,031,025

G

consortin, connexin sorting protein

increases expression

fenvalerate results in increased expression of CNST mRNA

PMID:23397585 PMID:30307764

NCBI chr13:91,296,740...91,373,531
Ensembl chr13:91,296,142...91,373,531

G

ciliary neurotrophic factor receptor

increases expression

fenvalerate results in increased expression of CNTFR mRNA

NCBI chr 5:56,823,448...56,861,049
Ensembl chr 5:56,823,965...56,841,392

G

contactin 3

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CNTN3 protein

NCBI chr 4:134,841,268...135,214,460
Ensembl chr 4:134,842,266...135,125,613

G

collagen type X alpha 1 chain

decreases expression

fenvalerate results in decreased expression of COL10A1 mRNA

NCBI chr20:38,183,103...38,189,488
Ensembl chr20:38,182,494...38,189,494

G

collagen type I alpha 1 chain

increases expression

fenvalerate results in increased expression of COL1A1 mRNA

NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624

G

collagen type XXIII alpha 1 chain

increases expression

fenvalerate results in increased expression of COL23A1 mRNA

NCBI chr10:35,549,090...35,839,152
Ensembl chr10:35,549,113...35,836,314

G

collagen type XXVII alpha 1 chain

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of COL27A1 protein

NCBI chr 5:76,647,302...76,765,989
Ensembl chr 5:76,647,429...76,765,174

G

collagen type II alpha 1 chain

increases expression

fenvalerate results in increased expression of COL2A1 mRNA

NCBI chr 7:129,098,489...129,127,560
Ensembl chr 7:129,098,786...129,127,546

G

collagen type V alpha 3 chain

increases expression

fenvalerate results in increased expression of COL5A3 mRNA

NCBI chr 8:19,304,564...19,349,809
Ensembl chr 8:19,304,571...19,349,853

G

collectin sub-family member 12

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of COLEC12 protein

NCBI chr18:732,950...920,620
Ensembl chr18:732,950...920,618

G

COP1, E3 ubiquitin ligase

increases expression

fenvalerate results in increased expression of COP1 mRNA

NCBI chr13:71,467,164...71,561,826
Ensembl chr13:71,429,961...71,538,890

G

COP9 signalosome subunit 2

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of COPS2 protein

NCBI chr 3:113,084,174...113,110,090
Ensembl chr 3:113,084,176...113,109,947

G

COP9 signalosome subunit 7B

increases expression

fenvalerate results in increased expression of COPS7B mRNA

NCBI chr 9:87,238,132...87,263,967
Ensembl chr 9:87,238,375...87,263,967

G

cytochrome c oxidase subunit 5A

increases expression

fenvalerate results in increased expression of COX5A protein

NCBI chr 8:57,922,374...57,933,781
Ensembl chr 8:57,922,290...57,933,781

G

cytochrome c oxidase subunit 6B2

increases expression

fenvalerate results in increased expression of COX6B2 mRNA

NCBI chr 1:69,094,009...69,095,312

G

carboxypeptidase A1

increases expression

fenvalerate results in increased expression of CPA1 mRNA

NCBI chr 4:59,257,417...59,263,544
Ensembl chr 4:59,257,417...59,263,544

G

carboxypeptidase A3

increases expression

fenvalerate results in increased expression of CPA3 mRNA

NCBI chr 2:102,712,483...102,744,219
Ensembl chr 2:102,712,589...102,744,203

G

cytoplasmic polyadenylation element binding protein 1

increases expression

fenvalerate results in increased expression of CPEB1 mRNA

NCBI chr 1:135,300,048...135,407,688
Ensembl chr 1:135,300,461...135,409,760

G

ciliogenesis and planar polarity effector complex subunit 1

increases expression

fenvalerate results in increased expression of CPLANE1 mRNA

NCBI chr 2:57,269,195...57,369,580
Ensembl chr 2:57,268,884...57,369,500

G

complexin 3

increases expression

fenvalerate results in increased expression of CPLX3 mRNA

NCBI chr 8:58,003,535...58,010,297
Ensembl chr 8:58,003,535...58,010,297

G

CRACD like

increases expression

fenvalerate results in increased expression of CRACDL mRNA

NCBI chr 9:39,834,321...39,950,763
Ensembl chr 9:39,834,833...39,951,086

G

cAMP responsive element binding protein 1

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of CREB1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CREB1 mRNA

PMID:33051911 PMID:33396045 PMID:34896426

NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816

G

cAMP responsive element binding protein 3-like 4

increases expression

fenvalerate results in increased expression of CREB3L4 mRNA

NCBI chr 2:175,690,340...175,695,846
Ensembl chr 2:175,690,335...175,695,932

G

CREB binding protein

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of CREBBP mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CREBBP mRNA

PMID:33051911 PMID:33396045 PMID:34896426

NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888

G

CREB3 regulatory factor

increases expression

fenvalerate results in increased expression of CREBRF mRNA

NCBI chr10:16,399,170...16,479,650
Ensembl chr10:16,404,596...16,461,999

G

cAMP responsive element modulator

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CREM mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CREM mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of CREM mRNA

PMID:33396045 PMID:34896426 PMID:36053783

NCBI chr17:54,238,889...54,305,989
Ensembl chr17:54,239,030...54,305,989

G

cartilage acidic protein 1

increases expression

fenvalerate results in increased expression of CRTAC1 mRNA

NCBI chr 1:241,091,679...241,233,677
Ensembl chr 1:241,078,864...241,233,421

G

crystallin, beta A1

decreases expression

fenvalerate results in decreased expression of CRYBA1 mRNA

NCBI chr10:62,608,373...62,614,726
Ensembl chr10:62,608,383...62,614,726

G

cold shock domain containing C2

decreases expression

fenvalerate results in decreased expression of CSDC2 mRNA

NCBI chr 7:113,451,998...113,466,464
Ensembl chr 7:113,451,998...113,466,463

G

colony stimulating factor 1

increases expression

fenvalerate results in increased expression of CSF1 mRNA

NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:195,377,215...195,411,704

G

casein kinase 1, epsilon

increases expression

fenvalerate results in increased expression of CSNK1E mRNA

NCBI chr 7:110,983,322...111,006,926
Ensembl chr 7:110,983,318...111,006,794

G

casein kinase 1, gamma 3

increases expression

fenvalerate results in increased expression of CSNK1G3 mRNA

NCBI chr18:47,299,547...47,386,538
Ensembl chr18:47,299,579...47,386,535

G

cystatin D

increases expression

fenvalerate results in increased expression of CST5 mRNA

NCBI chr 3:137,573,194...137,577,754
Ensembl chr 3:137,573,194...137,577,754

G

cystatin E/M

increases expression

fenvalerate results in increased expression of CST6 mRNA

NCBI chr 1:202,655,322...202,657,030
Ensembl chr 1:202,655,322...202,657,030

G

CTD small phosphatase like

increases expression

fenvalerate results in increased expression of CTDSPL mRNA

NCBI chr 8:118,642,729...118,767,238
Ensembl chr 8:118,642,672...118,767,117

G

catenin delta 2

increases expression

fenvalerate results in increased expression of CTNND2 mRNA

NCBI chr 2:81,168,525...82,016,495
Ensembl chr 2:81,167,117...82,015,764

G

cystinosin, lysosomal cystine transporter

increases expression

fenvalerate results in increased expression of CTNS mRNA

NCBI chr10:57,801,551...57,817,213
Ensembl chr10:57,801,456...57,817,120

G

cullin 9

increases expression

fenvalerate results in increased expression of CUL9 mRNA

NCBI chr 9:14,435,948...14,479,552
Ensembl chr 9:14,436,111...14,479,548

G

CUB and zona pellucida-like domains 1

increases expression

fenvalerate results in increased expression of CUZD1 mRNA

NCBI chr 1:186,089,422...186,130,536
Ensembl chr 1:186,089,423...186,102,546

G

C-X3-C motif chemokine ligand 1

decreases expression

fenvalerate results in decreased expression of CX3CL1 mRNA

NCBI chr19:10,227,337...10,237,826
Ensembl chr19:10,227,340...10,236,833

G

C-X-C motif chemokine ligand 14

decreases expression

fenvalerate results in decreased expression of CXCL14 mRNA

NCBI chr17:8,317,930...8,325,956
Ensembl chr17:8,317,933...8,324,839

G

C-X-C motif chemokine receptor 2

increases expression

fenvalerate results in increased expression of CXCR2 mRNA

NCBI chr 9:75,729,493...75,735,868
Ensembl chr 9:75,729,115...75,739,425

G

cytochrome b-245 beta chain

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CYBB mRNA

NCBI chr X:13,358,101...13,392,570
Ensembl chr X:13,359,430...13,392,586

G

cytochrome P450, family 11, subfamily a, polypeptide 1

decreases activity
increases expression
decreases expression
multiple interactions

fenvalerate results in decreased activity of CYP11A1 protein
fenvalerate results in increased expression of CYP11A1 mRNA
fenvalerate results in decreased expression of CYP11A1 mRNA; fenvalerate results in decreased expression of CYP11A1 protein
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in increased expression of CYP11A1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of CYP11A1 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of CYP11A1 mRNA

PMID:15907653 PMID:16001830 PMID:18053657 PMID:19683566 PMID:19892000 More...

NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338

G

cytochrome P450, family 17, subfamily a, polypeptide 1

decreases expression
multiple interactions

fenvalerate results in decreased expression of CYP17A1 mRNA; fenvalerate results in decreased expression of CYP17A1 protein
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of CYP17A1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CYP17A1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CYP17A1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CYP17A1 protein; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of CYP17A1 mRNA

PMID:20063364 PMID:20138952 PMID:33051911 PMID:33396045 PMID:34896426 More...

NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573

G

cytochrome P450, family 19, subfamily a, polypeptide 1

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of CYP19A1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CYP19A1 mRNA

PMID:33051911 PMID:33396045

NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758

G

cytochrome P450, family 1, subfamily a, polypeptide 2

increases activity

fenvalerate results in increased activity of CYP1A2 protein

NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312

G

cytochrome P450, family 2, subfamily b, polypeptide 1

increases expression

fenvalerate results in increased expression of CYP2B1 mRNA

NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052

G

cytochrome P450, family 2, subfamily b, polypeptide 12

increases expression

fenvalerate results in increased expression of CYP2B12 mRNA

NCBI chr 1:82,007,609...82,019,409
Ensembl chr 1:82,007,609...82,080,480

G

cytochrome P450, family 2, subfamily b, polypeptide 3

increases activity
increases expression
multiple interactions
decreases activity

fenvalerate results in increased activity of CYP2B6 protein
fenvalerate results in increased expression of CYP2B6 mRNA; fenvalerate results in increased expression of CYP2B6 protein
fenvalerate inhibits the reaction [CYP2B6 protein results in increased hydroxylation of Bupropion]
fenvalerate results in decreased activity of CYP2B6 protein

PMID:15548381 PMID:22310298 PMID:22634058

NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143

G

cytochrome P450, family 2, subfamily C, polypeptide 6

increases expression

fenvalerate results in increased expression of CYP2C19 mRNA

NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596

G

cytochrome P450, family 2, subfamily c, polypeptide 79

increases expression

fenvalerate results in increased expression of CYP2C8 mRNA

G

cytochrome P450, family 2, subfamily d, polypeptide 4

decreases activity

fenvalerate results in decreased activity of CYP2D6 protein

NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759

G

cytochrome P450, family 2, subfamily e, polypeptide 1

multiple interactions
decreases activity

fenvalerate inhibits the reaction [CYP2E1 protein results in increased hydroxylation of Chlorzoxazone]
fenvalerate results in decreased activity of CYP2E1 protein

NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023

G

cytochrome P450, family 3, subfamily a, polypeptide 2

increases activity
decreases activity
multiple interactions
increases expression

fenvalerate results in increased activity of CYP3A4 protein
fenvalerate results in decreased activity of CYP3A4 protein
Dexamethasone promotes the reaction [fenvalerate results in increased expression of CYP3A4 mRNA]; fenvalerate promotes the reaction [Dexamethasone results in increased expression of CYP3A4 mRNA]
fenvalerate results in increased expression of CYP3A4 mRNA; fenvalerate results in increased expression of CYP3A4 protein

PMID:15548381 PMID:19249324 PMID:20599767 PMID:22310298 PMID:22634058

NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008

G

cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1

multiple interactions
increases expression

Dexamethasone promotes the reaction [fenvalerate results in increased expression of CYP3A23-3A1 mRNA]; fenvalerate promotes the reaction [Dexamethasone results in increased expression of CYP3A23-3A1 mRNA]

NCBI chr12:9,256,159...9,285,020
Ensembl chr12:9,254,475...9,285,030
Ensembl chr12:9,254,475...9,285,030

G

cytochrome P450, family 4, subfamily a, polypeptide 1

increases activity
increases expression

fenvalerate metabolite results in increased activity of CYP4A22 protein
fenvalerate metabolite results in increased expression of CYP4A22 protein

NCBI chr 5:129,123,323...129,137,464
Ensembl chr 5:129,123,336...129,137,464

G

cytochrome P450, family 4, subfamily f, polypeptide 4

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CYP4F4 protein

NCBI chr 7:11,717,208...11,733,507
Ensembl chr 7:11,717,208...11,733,506

G

cytochrome P450, family 4, subfamily v, polypeptide 3

increases expression

fenvalerate results in increased expression of CYP4V3 mRNA

NCBI chr16:46,917,929...46,958,735
Ensembl chr16:46,918,401...46,943,395

G

cytochrome P450 family 7 subfamily A member 1

decreases expression

fenvalerate results in decreased expression of CYP7A1 mRNA

NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688

G

cysteinyl leukotriene receptor 1

increases expression

fenvalerate results in increased expression of CYSLTR1 mRNA

NCBI chr X:71,661,421...71,690,012
Ensembl chr X:71,663,821...71,690,121

G

cysteinyl leukotriene receptor 2

increases expression

fenvalerate results in increased expression of CYSLTR2 mRNA

NCBI chr15:48,189,476...48,228,750
Ensembl chr15:48,189,073...48,304,136

G

cystatin S

increases expression

fenvalerate results in increased expression of CYSS mRNA

NCBI chr 3:137,432,049...137,436,654
Ensembl chr 3:137,432,049...137,436,610

G

cytohesin 1

decreases expression

fenvalerate results in decreased expression of CYTH1 mRNA

NCBI chr10:103,402,727...103,485,826
Ensembl chr10:103,366,145...103,485,760

G

cytohesin 3

increases expression

fenvalerate results in increased expression of CYTH3 mRNA

NCBI chr12:10,840,137...10,933,792
Ensembl chr12:10,840,157...10,933,812

G

CXXC motif containing zinc binding protein

increases expression

fenvalerate results in increased expression of CZIB protein

NCBI chr 5:122,648,333...122,657,767
Ensembl chr 5:122,648,411...122,656,910

G

dishevelled-binding antagonist of beta-catenin 1

increases expression

fenvalerate results in increased expression of DACT1 mRNA

NCBI chr 6:89,790,676...89,818,254
Ensembl chr 6:89,790,644...89,817,906

G

dystroglycan 1

increases expression

fenvalerate results in increased expression of DAG1 mRNA

NCBI chr 8:108,890,926...108,955,611
Ensembl chr 8:108,890,929...108,952,325

G

DAZ associated protein 1

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DAZAP1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of DAZAP1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DAZAP1 mRNA

PMID:33051911 PMID:33396045 PMID:34896426

NCBI chr 7:9,423,673...9,448,116
Ensembl chr 7:9,424,178...9,538,818

G

D-box binding PAR bZIP transcription factor

decreases expression

fenvalerate results in decreased expression of DBP mRNA

NCBI chr 1:96,175,796...96,180,745
Ensembl chr 1:96,175,440...96,180,745

G

dihydrolipoamide branched chain transacylase E2

increases expression

fenvalerate results in increased expression of DBT mRNA

NCBI chr 2:204,481,744...204,510,612
Ensembl chr 2:204,481,737...204,510,609

G

DDB1 and CUL4 associated factor 6

increases expression

fenvalerate results in increased expression of DCAF6 mRNA

NCBI chr13:77,626,257...77,727,645
Ensembl chr13:77,626,307...77,727,512

G

DNA cross-link repair 1B

increases expression

fenvalerate results in increased expression of DCLRE1B mRNA

NCBI chr 2:191,309,909...191,318,399
Ensembl chr 2:191,309,913...191,318,423

G

dynactin subunit 2

increases expression

fenvalerate results in increased expression of DCTN2 protein

NCBI chr 7:63,092,061...63,107,560
Ensembl chr 7:63,092,057...63,108,543

G

discoidin domain receptor tyrosine kinase 1

increases expression
multiple interactions

fenvalerate results in increased expression of DDR1 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DDR1 protein

PMID:30307764 PMID:34896426

NCBI chr20:3,042,494...3,064,442
Ensembl chr20:3,044,320...3,064,468

G

DEAD/H-box helicase 11

increases expression

fenvalerate results in increased expression of DDX11 mRNA

NCBI chr 9:105,833,234...105,862,844
Ensembl chr 9:105,833,504...105,862,550

G

DEAD-box helicase 17

increases expression

fenvalerate results in increased expression of DDX17 mRNA

NCBI chr 7:111,091,127...111,109,353
Ensembl chr 7:111,089,445...111,109,193

G

DEAD-box helicase 25

increases expression
multiple interactions

fenvalerate results in increased expression of DDX25 mRNA
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DDX25 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of DDX25 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DDX25 mRNA

PMID:30307764 PMID:33051911 PMID:33396045 PMID:34896426

NCBI chr 8:33,894,224...33,910,377
Ensembl chr 8:33,894,232...33,921,764

G

DEAD-box helicase 3, X-linked

increases expression

fenvalerate results in increased expression of DDX3X mRNA

NCBI chr X:9,479,532...9,493,169
Ensembl chr X:9,479,532...9,493,168

G

DEAD box helicase 3, Y-linked

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DDX3Y mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DDX3Y mRNA

PMID:33051911 PMID:33396045 PMID:34896426

NCBI chr Y:1,115,095...1,135,754
Ensembl chr Y:1,116,309...1,135,706

G

DEAD-box helicase 46

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DDX46 protein

NCBI chr17:8,942,070...8,988,440
Ensembl chr17:8,944,454...8,988,439

G

DExD-box helicase 50

increases expression

fenvalerate results in increased expression of DDX50 mRNA

NCBI chr20:30,561,623...30,591,324
Ensembl chr20:30,560,544...30,591,152

G

defensin beta 1

increases expression

fenvalerate results in increased expression of DEFB1 mRNA

NCBI chr16:70,298,862...70,313,604
Ensembl chr16:70,298,863...70,313,604

G

deuterosome assembly protein 1

increases expression

fenvalerate results in increased expression of DEUP1 mRNA

NCBI chr 8:12,380,300...12,442,649
Ensembl chr 8:12,380,302...12,442,199

G

DNA fragmentation factor subunit beta

increases expression

fenvalerate results in increased expression of DFFB mRNA

NCBI chr 5:164,522,446...164,534,733
Ensembl chr 5:164,522,463...164,534,628

G

diacylglycerol kinase, beta

increases expression

fenvalerate results in increased expression of DGKB mRNA

NCBI chr 6:54,640,948...55,397,210
Ensembl chr 6:54,641,614...55,397,043

G

diacylglycerol kinase, delta

increases expression

fenvalerate results in increased expression of DGKD mRNA

NCBI chr 9:88,516,686...88,607,349
Ensembl chr 9:88,516,715...88,607,345

G

diacylglycerol kinase epsilon

increases expression

fenvalerate results in increased expression of DGKE mRNA

NCBI chr10:73,853,030...73,877,334
Ensembl chr10:73,855,583...73,877,100

G

deoxyguanosine kinase

increases expression

fenvalerate results in increased expression of DGUOK mRNA

NCBI chr 4:115,987,101...116,014,733
Ensembl chr 4:115,979,094...116,014,733

G

desert hedgehog signaling molecule

increases expression

fenvalerate results in increased expression of DHH mRNA

NCBI chr 7:130,050,910...130,056,406
Ensembl chr 7:130,050,910...130,056,406

G

dehydrogenase/reductase 7C

increases expression

fenvalerate results in increased expression of DHRS7C mRNA

NCBI chr10:52,495,262...52,513,338
Ensembl chr10:52,495,262...52,513,338

G

DExH-box helicase 30

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DHX30 protein

NCBI chr 8:110,064,751...110,096,954
Ensembl chr 8:110,064,752...110,097,381

G

DExH-box helicase 34

increases expression

fenvalerate results in increased expression of DHX34 mRNA

NCBI chr 1:76,880,867...76,905,148
Ensembl chr 1:76,880,867...76,905,113

G

diaphanous-related formin 3

increases expression

fenvalerate results in increased expression of DIAPH3 mRNA

NCBI chr15:62,543,375...63,013,060
Ensembl chr15:62,543,375...63,012,975

G

iodothyronine deiodinase 3

increases expression

fenvalerate results in increased expression of DIO3 mRNA

NCBI chr 6:129,285,747...129,287,608
Ensembl chr 6:129,285,749...129,286,660

G

divergent protein kinase domain 2A

increases expression

fenvalerate results in increased expression of DIPK2A mRNA

NCBI chr 8:95,070,695...95,089,815
Ensembl chr 8:95,030,279...95,089,815

G

dihydrolipoamide dehydrogenase

decreases expression

fenvalerate results in decreased expression of DLD protein

NCBI chr 6:47,904,153...47,924,814
Ensembl chr 6:47,903,914...47,924,795

G

discs large MAGUK scaffold protein 2

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DLG2 protein

NCBI chr 1:144,451,653...146,503,949
Ensembl chr 1:144,451,472...146,499,475

G

discs large MAGUK scaffold protein 3

increases expression

fenvalerate results in increased expression of DLG3 mRNA

NCBI chr X:65,859,653...65,911,887
Ensembl chr X:65,860,172...65,910,322

G

DLG associated protein 1

increases expression

fenvalerate results in increased expression of DLGAP1 mRNA

NCBI chr 9:109,857,500...110,726,817
Ensembl chr 9:110,167,448...110,726,817

G

dihydrolipoamide S-succinyltransferase

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DLST protein

NCBI chr 6:104,758,511...104,783,296
Ensembl chr 6:104,758,631...104,783,296

G

distal-less homeobox 3

increases expression

fenvalerate results in increased expression of DLX3 mRNA

NCBI chr10:80,064,489...80,069,891
Ensembl chr10:80,064,489...80,069,872

G

distal-less homeobox 5

increases expression

fenvalerate results in increased expression of DLX5 mRNA

NCBI chr 4:34,999,139...35,003,504
Ensembl chr 4:34,999,139...35,003,407

G

distal membrane arm assembly component 2 like

decreases expression

fenvalerate results in decreased expression of DMAC2L protein

NCBI chr 6:88,205,580...88,223,934
Ensembl chr 6:88,205,700...88,223,933

G

doublesex and mab-3 related transcription factor 2

increases expression

fenvalerate results in increased expression of DMRT2 mRNA

NCBI chr 1:223,317,543...223,324,131
Ensembl chr 1:223,317,642...223,324,131

G

DMRT-like family C1c1

increases expression

fenvalerate results in increased expression of DMRTC1C1 mRNA

NCBI chr X:67,896,973...67,904,182
Ensembl chr X:67,896,974...67,904,182

G

dynein, axonemal, heavy chain 1

increases expression

fenvalerate results in increased expression of DNAH1 mRNA

NCBI chr16:6,455,514...6,517,103
Ensembl chr16:6,456,002...6,518,350

G

dynein, axonemal, heavy chain 17

increases expression

fenvalerate results in increased expression of DNAH17 mRNA

NCBI chr10:103,244,144...103,364,953
Ensembl chr10:103,249,363...103,364,901

G

dynein axonemal intermediate chain 7

increases expression

fenvalerate results in increased expression of DNAI7 mRNA

NCBI chr 4:178,143,499...178,179,871
Ensembl chr 4:178,143,500...178,179,980

G

DnaJ heat shock protein family (Hsp40) member B13

increases expression

fenvalerate results in increased expression of DNAJB13 mRNA

NCBI chr 1:154,848,586...154,863,042
Ensembl chr 1:154,848,594...154,862,963

G

DnaJ heat shock protein family (Hsp40) member B2

increases expression

fenvalerate results in increased expression of DNAJB2 mRNA

NCBI chr 9:76,731,060...76,739,278
Ensembl chr 9:76,731,065...76,739,277

G

DnaJ heat shock protein family (Hsp40) member B3

increases expression

fenvalerate results in increased expression of DNAJB3 mRNA

NCBI chr 9:88,795,542...88,796,555
Ensembl chr 9:88,795,488...88,796,560

G

DnaJ heat shock protein family (Hsp40) member C17

increases expression

fenvalerate results in increased expression of DNAJC17 mRNA

NCBI chr 3:106,162,197...106,195,771
Ensembl chr 3:106,162,197...106,195,751

G

DnaJ heat shock protein family (Hsp40) member C30

increases expression

fenvalerate results in increased expression of DNAJC30 mRNA

NCBI chr12:21,628,319...21,629,398
Ensembl chr12:21,626,450...21,629,408

G

dynamin 1-like

increases expression

fenvalerate results in increased expression of DNM1L mRNA

NCBI chr11:84,581,216...84,632,382
Ensembl chr11:84,581,216...84,631,482

G

DNA methyltransferase 1

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of DNMT1 mRNA

NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659

G

DNA methyltransferase 3 alpha

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DNMT3A mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DNMT3A mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of DNMT3A mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of DNMT3A mRNA

PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783

NCBI chr 6:26,791,517...26,902,161
Ensembl chr 6:26,822,609...26,896,687

G

DNA methyltransferase 3 beta

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DNMT3B mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of DNMT3B mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of DNMT3B mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of DNMT3B mRNA

PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783

NCBI chr 3:142,130,588...142,169,128
Ensembl chr 3:142,130,592...142,169,124

G

aspartyl aminopeptidase

decreases expression

fenvalerate results in decreased expression of DNPEP protein

NCBI chr 9:76,799,931...76,808,841
Ensembl chr 9:76,783,966...76,808,716

G

DOP1 leucine zipper like protein A

decreases expression

fenvalerate results in decreased expression of DOP1A mRNA

NCBI chr 8:87,415,266...87,517,935
Ensembl chr 8:87,414,593...87,518,353

G

diphthamide biosynthesis 7

decreases expression

fenvalerate results in decreased expression of DPH7 mRNA

NCBI chr 3:7,770,368...7,778,994
Ensembl chr 3:7,770,379...7,778,982

G

dolichyl-phosphate mannosyltransferase subunit 1, catalytic

increases expression

fenvalerate results in increased expression of DPM1 mRNA

NCBI chr 3:156,919,979...156,939,522
Ensembl chr 3:156,919,979...156,939,536

G

dynein regulatory complex subunit 12 homolog

increases expression

fenvalerate results in increased expression of CCDC153 mRNA

NCBI chr 8:44,576,528...44,584,345
Ensembl chr 8:44,577,836...44,584,338

G

dynein regulatory complex subunit 3

increases expression

fenvalerate results in increased expression of DRC3 mRNA

NCBI chr10:45,149,094...45,200,659
Ensembl chr10:45,157,354...45,199,369

G

dopamine receptor D3

increases expression

fenvalerate results in increased expression of DRD3 mRNA

NCBI chr11:56,879,689...56,931,901
Ensembl chr11:56,879,689...56,940,596

G

dopamine receptor D4

increases expression

fenvalerate results in increased expression of DRD4 mRNA

NCBI chr 1:196,396,366...196,400,824
Ensembl chr 1:196,396,366...196,399,553

G

dystrophin related protein 2

increases expression

fenvalerate results in increased expression of DRP2 mRNA

NCBI chr X:97,607,577...97,658,117
Ensembl chr X:97,607,719...97,655,684

G

DS cell adhesion molecule

increases expression

fenvalerate results in increased expression of DSCAM mRNA

NCBI chr11:35,921,924...36,507,100
Ensembl chr11:35,926,896...36,507,415

G

desmoglein 1

increases expression

fenvalerate results in increased expression of DSG1 mRNA

NCBI chr18:11,674,687...11,705,383
Ensembl chr18:11,674,402...11,703,443

G

dystonin

increases expression

fenvalerate results in increased expression of DST mRNA

NCBI chr 9:36,135,657...36,529,617
Ensembl chr 9:36,135,284...36,529,615

G

destrin, actin depolymerizing factor

decreases expression

fenvalerate results in decreased expression of DSTN protein

NCBI chr 3:131,284,647...131,311,361
Ensembl chr 3:131,284,648...131,311,379

G

dual oxidase 2

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DUOX2 protein

NCBI chr 3:109,223,809...109,247,023
Ensembl chr 3:109,226,924...109,245,902

G

dihydrouridine synthase 4-like

increases expression

fenvalerate results in increased expression of DUS4L mRNA

NCBI chr 6:48,228,111...48,242,553
Ensembl chr 6:48,228,111...48,242,449

G

dual specificity phosphatase 1

increases expression

fenvalerate results in increased expression of DUSP1 mRNA

NCBI chr10:16,680,478...16,683,275

G

dual specificity phosphatase 9

increases expression

fenvalerate results in increased expression of DUSP9 mRNA

NCBI chr X:151,351,897...151,355,822
Ensembl chr X:151,351,897...151,355,821

G

dishevelled segment polarity protein 2

increases expression

fenvalerate results in increased expression of DVL2 mRNA

NCBI chr10:54,723,356...54,732,823
Ensembl chr10:54,723,411...54,732,820

G

dynein cytoplasmic 2 heavy chain 1

increases expression

fenvalerate results in increased expression of DYNC2H1 mRNA

NCBI chr 8:4,189,067...4,412,183
Ensembl chr 8:4,189,257...4,412,183

G

DAZ interacting zinc finger protein 3

increases expression

fenvalerate results in increased expression of DZIP3 mRNA

NCBI chr11:51,823,235...51,893,353
Ensembl chr11:51,823,231...51,893,353

G

E2F transcription factor 8

increases expression

fenvalerate results in increased expression of E2F8 mRNA

NCBI chr 1:98,565,717...98,584,265
Ensembl chr 1:98,565,717...98,584,098

G

EBF transcription factor 2

increases expression

fenvalerate results in increased expression of EBF2 mRNA

NCBI chr15:41,435,509...41,634,403
Ensembl chr15:41,435,509...41,634,403

G

endothelin converting enzyme-like 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ECEL1 protein

NCBI chr 9:87,819,516...87,829,154
Ensembl chr 9:87,816,718...87,826,675

G

enoyl-CoA hydratase 1

decreases expression

fenvalerate results in decreased expression of ECH1 protein

NCBI chr 1:84,114,494...84,120,788
Ensembl chr 1:84,112,751...84,120,795

G

enhancer of mRNA decapping 3

decreases expression

fenvalerate results in decreased expression of EDC3 mRNA

NCBI chr 8:58,106,147...58,151,685
Ensembl chr 8:58,106,175...58,151,671

G

endothelin 2

increases expression

fenvalerate results in increased expression of EDN2 mRNA

NCBI chr 5:133,751,316...133,756,814
Ensembl chr 5:133,751,217...133,756,814

G

endothelin receptor type A

decreases expression

fenvalerate results in decreased expression of EDNRA mRNA

NCBI chr19:30,233,540...30,303,727
Ensembl chr19:30,233,571...30,297,049

G

eukaryotic elongation factor-2 kinase

increases expression

fenvalerate results in increased expression of EEF2K mRNA

NCBI chr 1:175,393,119...175,456,756
Ensembl chr 1:175,393,154...175,455,164

G

EEIG family member 2

increases expression

fenvalerate results in increased expression of EEIG2 mRNA

NCBI chr 2:196,608,499...196,663,371
Ensembl chr 2:196,608,499...196,663,371

G

EF-hand calcium binding domain 2

increases expression

fenvalerate results in increased expression of EFCAB2 mRNA

NCBI chr13:90,152,002...90,237,918
Ensembl chr13:90,152,185...90,238,218

G

EF-hand domain containing 2

increases expression

fenvalerate results in increased expression of EFHC2 mRNA

NCBI chr X:5,360,499...5,564,004
Ensembl chr X:5,360,617...5,560,970

G

EFR3 homolog A

increases expression

fenvalerate results in increased expression of EFR3A mRNA

NCBI chr 7:97,552,677...97,633,369
Ensembl chr 7:97,552,677...97,633,369

G

early growth response 3

increases expression

fenvalerate results in increased expression of EGR3 mRNA

NCBI chr15:45,150,335...45,156,052
Ensembl chr15:45,150,567...45,154,627

G

early growth response 4

increases expression

fenvalerate results in increased expression of EGR4 mRNA

NCBI chr 4:118,047,869...118,050,328
Ensembl chr 4:118,047,869...118,050,328

G

eukaryotic translation initiation factor 4A3

decreases expression

fenvalerate results in decreased expression of EIF4A3 protein

NCBI chr10:104,549,038...104,559,032
Ensembl chr10:104,549,038...104,559,057

G

elaC ribonuclease Z 2

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ELAC2 protein

NCBI chr10:49,632,308...49,655,614
Ensembl chr10:49,632,378...49,655,614

G

ELAV like RNA binding protein 2

increases expression

fenvalerate results in increased expression of ELAVL2 mRNA

NCBI chr 5:105,960,872...106,086,463
Ensembl chr 5:105,960,875...106,109,097

G

ELAV like RNA binding protein 4

increases expression

fenvalerate results in increased expression of ELAVL4 mRNA

NCBI chr 5:125,056,848...125,200,543
Ensembl chr 5:125,056,848...125,200,446

G

E74 like ETS transcription factor 2

increases expression

fenvalerate results in increased expression of ELF2 mRNA

NCBI chr 2:135,292,291...135,385,942
Ensembl chr 2:135,294,906...135,385,947

G

extracellular leucine-rich repeat and fibronectin type III domain containing 2

increases expression

fenvalerate results in increased expression of ELFN2 mRNA

NCBI chr 7:110,220,293...110,272,770
Ensembl chr 7:110,225,919...110,272,433

G

engulfment and cell motility 2

decreases expression

fenvalerate results in decreased expression of ELMO2 mRNA

NCBI chr 3:154,023,661...154,061,259
Ensembl chr 3:154,023,661...154,061,185

G

ELOVL fatty acid elongase 4

increases expression

fenvalerate results in increased expression of ELOVL4 mRNA

NCBI chr 8:84,702,916...84,729,466
Ensembl chr 8:84,702,362...84,729,697

G

ELOVL fatty acid elongase 6

decreases expression

fenvalerate results in decreased expression of ELOVL6 mRNA

NCBI chr 2:218,063,682...218,174,767
Ensembl chr 2:218,063,804...218,171,186

G

ENAH, actin regulator

increases expression

fenvalerate results in increased expression of ENAH mRNA

NCBI chr13:93,617,747...93,738,119
Ensembl chr13:93,626,944...93,740,955

G

endonuclease domain containing 1

increases expression

fenvalerate results in increased expression of ENDOD1 mRNA

NCBI chr 8:11,209,113...11,238,507
Ensembl chr 8:11,211,110...11,238,892

G

ectonucleoside triphosphate diphosphohydrolase 4

increases expression

fenvalerate results in increased expression of ENTPD4 mRNA

NCBI chr15:44,630,878...44,658,654
Ensembl chr15:44,630,873...44,658,706

G

E1A binding protein p300

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of EP300 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of EP300 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of EP300 mRNA

PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783

NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088
Ensembl chr 7:113,106,247...113,136,088

G

exosomal polycystin 1 interacting protein

increases expression

fenvalerate results in increased expression of EPCIP mRNA

NCBI chr11:30,307,842...30,325,829
Ensembl chr11:30,310,350...30,325,439

G

Eph receptor A3

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of EPHA3 protein

NCBI chr11:1,138,485...1,474,102
Ensembl chr11:1,140,985...1,473,900

G

Eph receptor A4

increases expression

fenvalerate results in increased expression of EPHA4 mRNA

NCBI chr 9:78,815,460...78,958,139
Ensembl chr 9:78,815,460...78,958,139

G

Eph receptor A6

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of EPHA6 protein

NCBI chr11:39,757,501...40,708,901
Ensembl chr11:39,757,181...40,698,311

G

Eph receptor A7

increases expression

fenvalerate results in increased expression of EPHA7 mRNA

NCBI chr 5:42,975,353...43,128,703
Ensembl chr 5:42,975,405...43,127,112

G

epoxide hydrolase 1

increases activity

fenvalerate metabolite results in increased activity of EPHX1 protein

NCBI chr13:92,714,315...92,744,105
Ensembl chr13:92,714,315...92,790,235

G

epoxide hydrolase 2

increases activity

fenvalerate metabolite results in increased activity of EPHX2 protein

NCBI chr15:40,289,901...40,327,632
Ensembl chr15:40,289,902...40,327,615

G

epoxide hydrolase 4

increases expression

fenvalerate results in increased expression of EPHX4 mRNA

NCBI chr14:2,343,376...2,372,680
Ensembl chr14:2,340,248...2,373,022

G

epsin 2

increases expression

fenvalerate results in increased expression of EPN2 mRNA

NCBI chr10:46,197,785...46,259,673
Ensembl chr10:46,197,785...46,259,642

G

endoplasmic reticulum aminopeptidase 1

increases expression

fenvalerate results in increased expression of ERAP1 mRNA

NCBI chr 2:3,931,817...3,970,735
Ensembl chr 2:3,931,904...3,972,447

G

erb-b2 receptor tyrosine kinase 3

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of ERBB3 protein

NCBI chr 7:994,549...1,015,876
Ensembl chr 7:996,225...1,015,525

G

ELKS/RAB6-interacting/CAST family member 2

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ERC2 protein

NCBI chr16:2,812,712...3,673,624
Ensembl chr16:2,848,620...3,670,776

G

ERCC excision repair 3, TFIIH core complex helicase subunit

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ERCC3 protein

NCBI chr18:23,883,613...23,914,326
Ensembl chr18:23,883,580...23,914,329

G

ERCC excision repair 8, CSA ubiquitin ligase complex subunit

increases expression

fenvalerate results in increased expression of ERCC8 mRNA

NCBI chr 2:39,647,393...39,686,229
Ensembl chr 2:39,647,452...39,684,859

G

ERH, mRNA splicing and mitosis factor like 1

increases expression

fenvalerate results in increased expression of ERHL1 mRNA

NCBI chr 2:132,570,276...132,573,582
Ensembl chr 2:132,570,285...132,573,604

G

ermin

increases expression

fenvalerate results in increased expression of ERMN mRNA

NCBI chr 3:42,628,160...42,633,816
Ensembl chr 3:42,626,309...42,633,744

G

endothelial cell-specific molecule 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of ESM1 protein

NCBI chr 2:44,876,067...44,884,805
Ensembl chr 2:44,876,067...44,884,804

G

estrogen receptor 1

increases activity
multiple interactions
affects binding
increases expression

fenvalerate results in increased activity of ESR1 protein
fenvalerate binds to and results in increased activity of ESR1 protein
fenvalerate binds to ESR1 protein
fenvalerate results in increased expression of ESR1 mRNA

PMID:12396874 PMID:15064155 PMID:16626760 PMID:20410157 PMID:24388911

NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002

G

estrogen receptor 2

multiple interactions

fenvalerate binds to and results in increased activity of ESR2 protein

NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919

G

electron transfer flavoprotein subunit alpha

increases expression

fenvalerate results in increased expression of ETFA protein

NCBI chr 8:55,835,115...55,891,890
Ensembl chr 8:55,835,134...55,891,969

G

exocyst complex component 3

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of EXOC3 protein

NCBI chr 1:29,091,298...29,122,056
Ensembl chr 1:29,091,294...29,122,045

G

EYA transcriptional coactivator and phosphatase 2

increases expression

fenvalerate results in increased expression of EYA2 mRNA

NCBI chr 3:154,335,598...154,519,006
Ensembl chr 3:154,335,400...154,518,793

G

enhancer of zeste 2 polycomb repressive complex 2 subunit

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in increased expression of EZH2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of EZH2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of EZH2 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of EZH2 mRNA

PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783

NCBI chr 4:76,624,399...76,687,362
Ensembl chr 4:76,624,399...76,687,362

G

F2R like trypsin receptor 1

increases expression

fenvalerate results in increased expression of F2RL1 mRNA

NCBI chr 2:26,772,274...26,785,226
Ensembl chr 2:26,772,278...26,785,226

G

coagulation factor VIII

increases expression

fenvalerate results in increased expression of F8 mRNA

NCBI chr18:140,848...172,330
Ensembl chr18:140,955...171,857

G

fatty acid binding protein 9

affects expression

fenvalerate affects the expression of FABP9 protein

NCBI chr 2:91,591,842...91,595,873
Ensembl chr 2:91,592,298...91,595,873

G

fatty acid desaturase 3

decreases expression

fenvalerate results in decreased expression of FADS3 mRNA

NCBI chr 1:206,685,667...206,702,538
Ensembl chr 1:206,685,894...206,704,769

G

fumarylacetoacetate hydrolase domain containing 2A

decreases expression

fenvalerate results in decreased expression of FAHD2A protein

NCBI chr 3:114,657,176...114,665,349
Ensembl chr 3:114,655,865...114,665,356

G

family with sequence similarity 110, member C

increases expression

fenvalerate results in increased expression of FAM110C mRNA

NCBI chr 6:47,638,466...47,644,723
Ensembl chr 6:47,638,276...47,644,634

G

family with sequence similarity 168, member A

increases expression

fenvalerate results in increased expression of FAM168A mRNA

NCBI chr 1:155,057,352...155,203,439
Ensembl chr 1:155,057,352...155,201,220

G

family with sequence similarity 171, member A1

increases expression

fenvalerate results in increased expression of FAM171A1 mRNA

NCBI chr17:75,024,582...75,148,348
Ensembl chr17:75,024,575...75,150,255

G

family with sequence similarity 181, member B

increases expression

fenvalerate results in increased expression of FAM181B mRNA

NCBI chr 1:147,166,428...147,167,925
Ensembl chr 1:147,124,740...147,168,298
Ensembl chr 1:147,124,740...147,168,298

G

family with sequence similarity 193, member A

increases expression

fenvalerate results in increased expression of FAM193A mRNA

NCBI chr14:76,250,103...76,382,525
Ensembl chr14:76,256,161...76,382,514

G

family with sequence similarity 209

increases expression

fenvalerate results in increased expression of FAM209 mRNA

NCBI chr 3:161,240,062...161,241,747
Ensembl chr 3:161,240,034...161,241,755

G

FAM20B, glycosaminoglycan xylosylkinase

increases expression

fenvalerate results in increased expression of FAM20B mRNA

NCBI chr13:68,801,663...68,839,979
Ensembl chr13:68,801,669...68,839,915

G

family with sequence similarity 219, member A

increases expression

fenvalerate results in increased expression of FAM219A mRNA

NCBI chr 5:56,679,272...56,729,959
Ensembl chr 5:56,680,613...56,729,924

G

family with sequence similarity 221, member A

increases expression

fenvalerate results in increased expression of FAM221A mRNA

NCBI chr 4:78,337,296...78,358,918
Ensembl chr 4:78,337,296...78,358,909

G

family with sequence similarity 241 member A

increases expression

fenvalerate results in increased expression of FAM241A mRNA

NCBI chr 2:216,344,563...216,375,193
Ensembl chr 2:216,343,822...216,375,242

G

family with sequence similarity 78, member B

increases expression

fenvalerate results in increased expression of FAM78B mRNA

NCBI chr13:79,162,393...79,250,958
Ensembl chr13:79,162,228...79,250,500

G

family with sequence similarity 81, member A

increases expression

fenvalerate results in increased expression of FAM81A mRNA

NCBI chr 8:70,762,852...70,821,898
Ensembl chr 8:70,763,614...70,821,875

G

family with sequence similarity 83, member F

increases expression

fenvalerate results in increased expression of FAM83F mRNA

NCBI chr 7:112,211,164...112,240,454
Ensembl chr 7:112,211,164...112,240,452

G

FA complementation group A

increases expression

fenvalerate results in increased expression of FANCA mRNA

NCBI chr19:51,304,126...51,362,586
Ensembl chr19:51,304,021...51,362,527

G

FA complementation group B

increases expression

fenvalerate results in increased expression of FANCB mRNA

NCBI chr X:29,403,771...29,420,484
Ensembl chr X:29,403,771...29,420,192

G

fatty acyl CoA reductase 1

increases expression

fenvalerate results in increased expression of FAR1 mRNA

NCBI chr 1:167,644,622...167,705,868
Ensembl chr 1:167,644,677...167,705,730

G

FERM, ARH/RhoGEF and pleckstrin domain protein 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of FARP1 protein

NCBI chr15:98,124,304...98,363,299
Ensembl chr15:98,182,329...98,363,299

G

Fas ligand

increases expression

fenvalerate results in increased expression of FASLG mRNA

NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215

G

fibulin 5

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of FBLN5 protein

NCBI chr 6:120,899,219...120,977,829
Ensembl chr 6:120,899,224...120,977,755

G

fibrosin-like 1

increases expression

fenvalerate results in increased expression of FBRSL1 mRNA

NCBI chr12:46,231,466...46,320,607
Ensembl chr12:46,231,495...46,320,357

G

F-box and leucine-rich repeat protein 22

increases expression

fenvalerate results in increased expression of FBXL22 mRNA

NCBI chr 8:67,069,998...67,076,685
Ensembl chr 8:67,069,998...67,076,685

G

F-box and leucine-rich repeat protein 6

decreases expression

fenvalerate results in decreased expression of FBXL6 mRNA

NCBI chr 7:108,259,097...108,262,528
Ensembl chr 7:108,257,160...108,262,513

G

F-box protein 10

increases expression

fenvalerate results in increased expression of FBXO10 mRNA

NCBI chr 5:59,297,016...59,343,429
Ensembl chr 5:59,297,045...59,343,348

G

F-box protein 28

increases expression

fenvalerate results in increased expression of FBXO28 mRNA

NCBI chr13:93,995,993...94,021,464
Ensembl chr13:93,995,996...94,021,464

G

F-box and WD repeat domain containing 2

increases expression

fenvalerate results in increased expression of FBXW2 mRNA

NCBI chr 3:18,088,859...18,114,387
Ensembl chr 3:18,088,865...18,114,381

G

F-box and WD repeat domain containing 8

decreases expression

fenvalerate results in decreased expression of FBXW8 mRNA

NCBI chr12:38,426,466...38,517,076
Ensembl chr12:38,426,444...38,516,424

G

FCH and mu domain containing endocytic adaptor 1

increases expression

fenvalerate results in increased expression of FCHO1 mRNA

NCBI chr16:18,413,452...18,430,795
Ensembl chr16:18,413,363...18,435,104

G

ficolin B

increases expression

fenvalerate results in increased expression of FCNB mRNA

NCBI chr 3:11,393,713...11,402,198
Ensembl chr 3:11,393,739...11,402,151

G

Fc receptor-like 6

increases expression

fenvalerate results in increased expression of FCRL6 mRNA

NCBI chr13:85,062,709...85,072,308
Ensembl chr13:85,066,694...85,072,600

G

fem-1 homolog B

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of FEM1B protein

NCBI chr 8:63,265,301...63,278,577
Ensembl chr 8:63,265,301...63,278,577

G

FES proto-oncogene, tyrosine kinase

increases expression

fenvalerate results in increased expression of FES mRNA

NCBI chr 1:134,337,698...134,346,934
Ensembl chr 1:134,337,698...134,346,934

G

fasciculation and elongation protein zeta 1

increases expression

fenvalerate results in increased expression of FEZ1 mRNA

NCBI chr 8:36,544,462...36,589,684
Ensembl chr 8:36,544,535...36,589,683

G

Fez family zinc finger 2

increases expression

fenvalerate results in increased expression of FEZF2 mRNA

NCBI chr15:12,768,614...12,777,554
Ensembl chr15:12,773,762...12,777,554

G

fibrinogen beta chain

increases expression

fenvalerate results in increased expression of FGB mRNA

NCBI chr 2:168,394,901...168,402,863
Ensembl chr 2:168,394,916...168,405,979

G

FYVE, RhoGEF and PH domain containing 4

increases expression

fenvalerate results in increased expression of FGD4 mRNA

NCBI chr11:84,399,989...84,551,013
Ensembl chr11:84,399,816...84,546,972

G

fibroblast growth factor 12

increases expression

fenvalerate results in increased expression of FGF12 mRNA

NCBI chr11:71,997,151...72,564,757
Ensembl chr11:71,997,099...72,562,607

G

fibroblast growth factor 13

increases expression

fenvalerate results in increased expression of FGF13 mRNA

NCBI chr X:137,276,498...137,800,056
Ensembl chr X:137,276,511...137,800,391

G

fibroblast growth factor 14

increases expression

fenvalerate results in increased expression of FGF14 mRNA

NCBI chr15:101,045,033...101,679,888
Ensembl chr15:101,045,036...101,679,900

G

fibroblast growth factor 3

increases expression

fenvalerate results in increased expression of FGF3 mRNA

NCBI chr 1:200,001,162...200,005,539
Ensembl chr 1:200,001,261...200,005,187

G

fibroblast growth factor 9

increases expression

fenvalerate results in increased expression of FGF9 mRNA

NCBI chr15:32,208,993...32,254,952
Ensembl chr15:32,210,074...32,253,309

G

fibrinogen-like 2

increases expression

fenvalerate results in increased expression of FGL2 mRNA

NCBI chr 4:13,710,566...13,716,207
Ensembl chr 4:13,710,575...13,716,207

G

four and a half LIM domains 2

increases expression

fenvalerate results in increased expression of FHL2 mRNA

NCBI chr 9:45,388,979...45,462,421
Ensembl chr 9:45,388,981...45,431,192

G

four and a half LIM domains 5

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of FHL5 protein

NCBI chr 5:38,907,941...38,956,759
Ensembl chr 5:38,907,946...38,956,552

G

fin bud initiation factor homolog

increases expression

fenvalerate results in increased expression of FIBIN mRNA

NCBI chr 3:96,942,405...96,944,676
Ensembl chr 3:96,942,406...96,944,676

G

filamin A interacting protein 1

increases expression

fenvalerate results in increased expression of FILIP1 mRNA

NCBI chr 8:80,761,283...80,956,556
Ensembl chr 8:80,764,604...80,922,549

G

filamin C

increases expression

fenvalerate results in increased expression of FLNC mRNA

NCBI chr 4:58,034,088...58,061,882
Ensembl chr 4:58,034,189...58,061,844

G

Fms related receptor tyrosine kinase 1

increases expression
multiple interactions

fenvalerate results in increased expression of FLT1 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of FLT1 protein

PMID:30307764 PMID:34896426

NCBI chr12:7,296,899...7,468,626
Ensembl chr12:7,297,292...7,468,626

G

Fms related receptor tyrosine kinase 4

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of FLT4 protein

NCBI chr10:33,913,725...33,954,770
Ensembl chr10:33,913,608...33,954,770

G

FLYWCH family member 2

increases expression

fenvalerate results in increased expression of FLYWCH2 mRNA

NCBI chr10:12,798,757...12,807,082
Ensembl chr10:12,798,762...12,806,439

G

flavin containing dimethylaniline monoxygenase 4

increases expression

fenvalerate results in increased expression of FMO4 mRNA

NCBI chr13:75,154,683...75,172,874
Ensembl chr13:75,154,684...75,172,874

G

flavin containing dimethylaniline monoxygenase 5

increases expression

fenvalerate results in increased expression of FMO5 mRNA

NCBI chr 2:185,197,184...185,249,699
Ensembl chr 2:185,222,204...185,249,693

G

formin binding protein 1

increases expression

fenvalerate results in increased expression of FNBP1 mRNA

NCBI chr 3:14,309,067...14,424,378
Ensembl chr 3:14,309,640...14,424,881

G

forkhead box C1

increases expression

fenvalerate results in increased expression of FOXC1 mRNA

NCBI chr17:32,631,379...32,635,361
Ensembl chr17:32,633,142...32,634,803

G

forkhead box O3

affects methylation

fenvalerate affects the methylation of FOXO3 gene

NCBI chr20:45,669,708...45,764,606
Ensembl chr20:45,672,995...45,764,561

G

fibroblast growth factor receptor substrate 2

increases expression

fenvalerate results in increased expression of FRS2 mRNA

NCBI chr 7:52,711,255...52,792,738
Ensembl chr 7:52,711,257...52,792,743

G

FRY like transcription coactivator

increases expression

fenvalerate results in increased expression of FRYL mRNA

NCBI chr14:34,956,623...35,189,738
Ensembl chr14:34,956,620...35,190,222

G

fascin actin-bundling protein 1

increases expression

fenvalerate results in increased expression of FSCN1 mRNA

NCBI chr12:11,597,042...11,610,183
Ensembl chr12:11,597,048...11,610,211

G

fascin actin-bundling protein 2, retinal

increases expression

fenvalerate results in increased expression of FSCN2 mRNA

NCBI chr10:105,634,783...105,641,322
Ensembl chr10:105,634,783...105,641,322

G

follicle stimulating hormone subunit beta

increases expression
multiple interactions

fenvalerate results in increased expression of FSHB mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of FSHB protein; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of FSHB protein

PMID:30307764 PMID:34896426 PMID:36053783

NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370

G

follicle stimulating hormone receptor

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of FSHR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of FSHR mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of FSHR mRNA

PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783

NCBI chr 6:5,198,825...5,406,785
Ensembl chr 6:5,198,825...5,406,785

G

follistatin-like 4

increases expression

fenvalerate results in increased expression of FSTL4 mRNA

NCBI chr10:36,911,422...37,344,545
Ensembl chr10:36,911,420...37,338,588

G

forty-two-three domain containing 1

increases expression

fenvalerate results in increased expression of FYTTD1 mRNA

NCBI chr11:67,877,967...67,907,500
Ensembl chr11:67,877,967...67,907,511

G

fizzy and cell division cycle 20 related 1

increases expression

fenvalerate results in increased expression of FZR1 mRNA

NCBI chr 7:8,332,029...8,343,953
Ensembl chr 7:8,332,029...8,343,952

G

glucose-6-phosphate dehydrogenase

decreases activity

fenvalerate results in decreased activity of G6PDX protein

NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801

G

GABA type A receptor-associated protein

increases expression

fenvalerate results in increased expression of GABARAP mRNA

NCBI chr10:54,714,777...54,718,099
Ensembl chr10:54,714,198...54,717,765

G

gamma-aminobutyric acid type B receptor subunit 1

increases expression

fenvalerate results in increased expression of GABBR1 mRNA

NCBI chr20:1,464,534...1,494,114
Ensembl chr20:1,464,534...1,493,994

G

gamma-aminobutyric acid type A receptor subunit gamma 1

increases expression

fenvalerate results in increased expression of GABRG1 mRNA

NCBI chr14:37,396,217...37,469,606
Ensembl chr14:37,396,294...37,635,956

G

gamma-aminobutyric acid type A receptor subunit gamma 2

increases expression

fenvalerate results in increased expression of GABRG2 mRNA

NCBI chr10:26,374,693...26,463,937
Ensembl chr10:26,374,694...26,464,346

G

gamma-aminobutyric acid type A receptor subunit gamma 3

increases expression

fenvalerate results in increased expression of GABRG3 mRNA

NCBI chr 1:107,627,450...108,247,483
Ensembl chr 1:107,627,390...108,246,763

G

galactose-3-O-sulfotransferase 1

increases expression

fenvalerate results in increased expression of GAL3ST1 mRNA

NCBI chr14:78,868,049...78,886,402
Ensembl chr14:78,870,793...78,886,388

G

galactokinase 1

increases expression

fenvalerate results in increased expression of GALK1 protein

NCBI chr10:101,243,146...101,247,323
Ensembl chr10:101,235,994...101,247,337

G

galactose mutarotase

decreases expression

fenvalerate results in decreased expression of GALM protein

NCBI chr 6:14,837,540...14,889,484
Ensembl chr 6:14,837,548...14,889,310

G

polypeptide N-acetylgalactosaminyltransferase 14

increases expression

fenvalerate results in increased expression of GALNT14 mRNA

NCBI chr 6:21,756,039...21,977,533
Ensembl chr 6:21,755,195...21,972,192

G

polypeptide N-acetylgalactosaminyltransferase 16

increases expression

fenvalerate results in increased expression of GALNT16 mRNA

NCBI chr 6:100,168,943...100,250,718
Ensembl chr 6:100,170,306...100,250,705

G

growth associated protein 43

increases expression

fenvalerate results in increased expression of GAP43 mRNA

NCBI chr11:58,376,371...58,470,047
Ensembl chr11:58,376,371...58,470,045

G

glyceraldehyde-3-phosphate dehydrogenase, pseudogene 2

increases expression

fenvalerate results in increased expression of GAPDH-PS2 protein

Ensembl chr16:24,029,964...24,031,270

G

glyceraldehyde-3-phosphate dehydrogenase, spermatogenic

decreases expression

fenvalerate results in decreased expression of GAPDHS protein

NCBI chr 1:85,979,096...85,994,153
Ensembl chr 1:85,979,098...85,993,640

G

golgi associated RAB2 interactor family member 4

increases expression

fenvalerate results in increased expression of GARIN4 mRNA

NCBI chr13:102,742,988...102,745,168
Ensembl chr13:102,742,988...102,745,168

G

glycyl-tRNA synthetase 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GARS1 protein

NCBI chr 4:84,171,596...84,212,609
Ensembl chr 4:84,171,596...84,212,609

G

gastrin

increases expression

fenvalerate results in increased expression of GAST mRNA

NCBI chr10:85,264,832...85,269,393
Ensembl chr10:85,264,832...85,267,496

G

GATA binding protein 1

increases expression

fenvalerate results in increased expression of GATA1 mRNA

NCBI chr X:14,529,706...14,537,530
Ensembl chr X:14,529,702...14,537,530

G

GATA binding protein 4

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of GATA4 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of GATA4 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of GATA4 mRNA

PMID:33051911 PMID:34896426 PMID:36053783

NCBI chr15:37,459,601...37,531,291
Ensembl chr15:37,459,601...37,505,636

G

GC, vitamin D binding protein

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GC protein

NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,632,135...18,667,567

G

glutamate-cysteine ligase, catalytic subunit

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GCLC protein

NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544

G

growth differentiation factor 10

increases expression

fenvalerate results in increased expression of GDF10 mRNA

NCBI chr16:9,237,182...9,250,537
Ensembl chr16:9,237,261...9,249,343

G

glial cell derived neurotrophic factor

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of GDNF mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of GDNF mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of GDNF mRNA

PMID:33051911 PMID:33396045 PMID:34896426

NCBI chr 2:56,894,022...56,919,935
Ensembl chr 2:56,895,010...56,917,209

G

GDNF family receptor alpha 1

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of GFRA1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GFRA1 mRNA

PMID:33051911 PMID:33396045 PMID:34896426

NCBI chr 1:257,315,682...257,552,004
Ensembl chr 1:257,321,742...257,551,473

G

gamma-glutamyltransferase 1

affects expression
increases expression

fenvalerate affects the expression of GGT1
fenvalerate results in increased expression of GGT1 mRNA

PMID:12479040 PMID:30307764

NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442

G

growth hormone 1

increases expression

fenvalerate results in increased expression of GH1 mRNA

NCBI chr10:91,228,102...91,230,079
Ensembl chr10:91,228,103...91,230,078

G

GTPase, IMAP family member 8

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GIMAP8 protein

NCBI chr 4:77,600,104...77,611,593
Ensembl chr 4:77,600,186...77,611,590

G

GIT ArfGAP 2

increases expression

fenvalerate results in increased expression of GIT2 mRNA

NCBI chr12:41,829,717...41,872,621
Ensembl chr12:41,829,730...41,871,097

G

gap junction protein, alpha 3

increases expression

fenvalerate results in increased expression of GJA3 mRNA

NCBI chr15:31,181,360...31,206,820
Ensembl chr15:31,181,369...31,206,810

G

gap junction protein, alpha 4

decreases expression

fenvalerate results in decreased expression of GJA4 mRNA

NCBI chr 5:139,633,324...139,635,857
Ensembl chr 5:139,633,287...139,635,925

G

gap junction protein, alpha 5

increases expression

fenvalerate results in increased expression of GJA5 mRNA

NCBI chr 2:184,602,407...184,621,952
Ensembl chr 2:184,564,475...184,621,952

G

gap junction protein, beta 3

increases expression

fenvalerate results in increased expression of GJB3 mRNA

NCBI chr 5:139,649,227...139,654,970
Ensembl chr 5:139,649,195...139,654,980

G

gliadoralin-A like

increases expression

fenvalerate results in increased expression of GLAL mRNA

NCBI chr 4:165,928,441...165,931,317
Ensembl chr 4:165,922,843...165,989,527

G

glyoxalase domain containing 4

increases expression

fenvalerate results in increased expression of GLOD4 protein

NCBI chr10:61,077,535...61,095,876
Ensembl chr10:61,066,421...61,095,898

G

glutaminase

increases expression

fenvalerate results in increased expression of GLS mRNA

NCBI chr 9:49,344,616...49,416,900
Ensembl chr 9:49,344,781...49,416,900

G

glutamate-ammonia ligase

increases expression

fenvalerate results in increased expression of GLUL protein

NCBI chr13:65,969,053...66,035,121
Ensembl chr13:66,025,630...66,035,108

G

glia maturation factor, beta

increases expression

fenvalerate results in increased expression of GMFB protein

NCBI chr15:20,069,923...20,081,005
Ensembl chr15:20,067,263...20,080,331

G

guanine monophosphate synthase

decreases expression

fenvalerate results in decreased expression of GMPS protein

NCBI chr 2:148,441,369...148,491,908
Ensembl chr 2:148,435,643...148,485,875

G

G protein subunit alpha 14

decreases expression

fenvalerate results in decreased expression of GNA14 mRNA

NCBI chr 1:213,714,993...213,900,083
Ensembl chr 1:213,716,020...213,897,423

G

G protein subunit alpha i1

increases expression

fenvalerate results in increased expression of GNAI1 mRNA

NCBI chr 4:16,814,000...16,898,119
Ensembl chr 4:16,814,001...16,896,417

G

G protein subunit alpha o1

increases expression

fenvalerate results in increased expression of GNAO1 mRNA

NCBI chr19:11,034,874...11,192,531
Ensembl chr19:11,035,956...11,192,493

G

G protein subunit beta 2

increases expression

fenvalerate results in increased expression of GNB2 protein

NCBI chr12:19,159,002...19,164,021
Ensembl chr12:19,158,973...19,164,019

G

G protein subunit gamma 13

increases expression

fenvalerate results in increased expression of GNG13 mRNA

NCBI chr10:14,741,179...14,743,083
Ensembl chr10:14,741,239...14,743,083

G

G protein nucleolar 1

decreases expression
multiple interactions

fenvalerate results in decreased expression of GNL1 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GNL1 protein

PMID:30307764 PMID:34896426

NCBI chr20:2,783,130...2,792,115
Ensembl chr20:2,778,985...2,792,115

G

gonadotropin releasing hormone 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of GNRH1 protein

NCBI chr15:41,972,482...41,976,690
Ensembl chr15:41,972,905...41,973,581
Ensembl chr15:41,972,905...41,973,581

G

glucosamine (N-acetyl)-6-sulfatase

increases expression

fenvalerate results in increased expression of GNS mRNA

NCBI chr 7:56,889,148...56,923,173
Ensembl chr 7:56,889,232...56,923,151

G

golgi integral membrane protein 4

increases expression

fenvalerate results in increased expression of GOLIM4 mRNA

NCBI chr 2:160,640,837...160,733,475
Ensembl chr 2:160,640,938...160,733,253

G

gon-4 like

increases expression

fenvalerate results in increased expression of GON4L mRNA

NCBI chr 2:174,233,461...174,306,636
Ensembl chr 2:174,233,461...174,306,634

G

glutamic-oxaloacetic transaminase 1

increases activity

fenvalerate results in increased activity of GOT1 protein

NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633

G

glypican 3

increases expression

fenvalerate results in increased expression of GPC3 mRNA

NCBI chr X:131,868,986...132,236,824
Ensembl chr X:131,868,990...132,236,798

G

gephyrin

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GPHN protein

NCBI chr 6:96,954,365...97,483,617
Ensembl chr 6:96,892,148...97,483,612

G

glycoprotein m6a

increases expression

fenvalerate results in increased expression of GPM6A mRNA

NCBI chr16:36,641,282...36,973,377
Ensembl chr16:36,641,284...36,973,475

G

G protein-coupled receptor 153

decreases expression

fenvalerate results in decreased expression of GPR153 mRNA

NCBI chr 5:162,781,587...162,792,975
Ensembl chr 5:162,781,587...162,792,971

G

G protein-coupled receptor 162

increases expression

fenvalerate results in increased expression of GPR162 mRNA

NCBI chr 4:157,662,200...157,668,341
Ensembl chr 4:157,662,200...157,668,121

G

G protein-coupled receptor 176

increases expression

fenvalerate results in increased expression of GPR176 mRNA

NCBI chr 3:105,236,794...105,337,664
Ensembl chr 3:105,236,795...105,337,226

G

G protein-coupled receptor 20

increases expression

fenvalerate results in increased expression of GPR20 mRNA

NCBI chr 7:105,601,761...105,611,959
Ensembl chr 7:105,602,368...105,603,430

G

G protein-coupled receptor 83

increases expression

fenvalerate results in increased expression of GPR83 mRNA

NCBI chr 8:11,693,540...11,704,028
Ensembl chr 8:11,693,540...11,704,028

G

G protein-coupled receptor 85

increases expression

fenvalerate results in increased expression of GPR85 mRNA

NCBI chr 4:42,100,138...42,109,584
Ensembl chr 4:42,102,941...42,109,566

G

G protein-coupled receptor associated sorting protein 2

increases expression

fenvalerate results in increased expression of GPRASP2 mRNA

NCBI chr X:98,817,668...98,823,814
Ensembl chr X:98,817,593...98,824,402

G

glutamic--pyruvic transaminase

increases activity
multiple interactions

fenvalerate results in increased activity of GPT protein
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the activity of GPT protein; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased activity of GPT protein

PMID:15186033 PMID:33396045 PMID:35678313

NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494

G

glutathione peroxidase 4

affects expression

fenvalerate affects the expression of GPX4 protein

NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982

G

GRB2-related adaptor protein 2

increases expression

fenvalerate results in increased expression of GRAP2 mRNA

NCBI chr 7:112,117,142...112,190,880
Ensembl chr 7:112,117,142...112,190,877

G

growth regulating estrogen receptor binding 1

increases expression

fenvalerate results in increased expression of GREB1 mRNA

NCBI chr 6:39,440,522...39,562,364
Ensembl chr 6:39,440,504...39,581,633

G

gremlin 1, DAN family BMP antagonist

increases expression

fenvalerate results in increased expression of GREM1 mRNA

NCBI chr 3:100,512,317...100,524,001
Ensembl chr 3:100,512,313...100,524,082

G

grainyhead-like transcription factor 1

increases expression

fenvalerate results in increased expression of GRHL1 mRNA

NCBI chr 6:41,207,325...41,257,516
Ensembl chr 6:41,207,348...41,254,301

G

glutamate ionotropic receptor AMPA type subunit 2

decreases expression
increases expression

fenvalerate results in decreased expression of GRIA2 protein
fenvalerate results in increased expression of GRIA2 mRNA

PMID:26961610 PMID:30307764

NCBI chr 2:165,949,379...166,069,510
Ensembl chr 2:165,947,521...166,069,510

G

glutamate ionotropic receptor AMPA type subunit 3

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GRIA3 protein

NCBI chr X:120,238,515...120,504,106
Ensembl chr X:120,238,534...120,504,096

G

glutamate ionotropic receptor AMPA type subunit 4

increases expression

fenvalerate results in increased expression of GRIA4 mRNA

NCBI chr 8:1,562,118...2,035,035
Ensembl chr 8:1,562,119...2,034,979

G

glutamate ionotropic receptor kainate type subunit 2

increases expression

fenvalerate results in increased expression of GRIK2 mRNA

NCBI chr20:52,135,325...52,833,061
Ensembl chr20:52,133,851...52,838,375

G

glutamate ionotropic receptor kainate type subunit 5

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GRIK5 protein

NCBI chr 1:80,605,878...80,667,896
Ensembl chr 1:80,605,892...80,667,125

G

glutamate ionotropic receptor NMDA type subunit 1

increases expression
decreases expression

fenvalerate results in increased expression of GRIN1 mRNA
fenvalerate results in decreased expression of GRIN1 mRNA

PMID:30307764 PMID:34748853

NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603

G

glutamate ionotropic receptor NMDA type subunit 2D

increases expression

fenvalerate results in increased expression of GRIN2D mRNA

NCBI chr 1:96,306,871...96,346,994
Ensembl chr 1:96,308,365...96,344,793

G

glutamate ionotropic receptor NMDA type subunit 3A

increases expression

fenvalerate results in increased expression of GRIN3A mRNA

NCBI chr 5:64,006,847...64,206,408
Ensembl chr 5:64,009,980...64,206,085

G

glutamate ionotropic receptor NMDA type subunit 3B

increases expression

fenvalerate results in increased expression of GRIN3B mRNA

NCBI chr 7:9,730,861...9,737,183
Ensembl chr 7:9,730,862...9,737,183

G

glutamate receptor interacting protein 2

increases expression

fenvalerate results in increased expression of GRIP2 mRNA

NCBI chr 4:124,271,456...124,356,538
Ensembl chr 4:124,271,456...124,321,268

G

glutamate metabotropic receptor 1

increases expression
multiple interactions

fenvalerate results in increased expression of GRM1 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GRM1 protein

PMID:30307764 PMID:34896426

NCBI chr 1:5,058,285...5,453,170
Ensembl chr 1:5,058,292...5,453,170

G

glutamate metabotropic receptor 5

increases expression
multiple interactions

fenvalerate results in increased expression of GRM5 mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GRM5 protein

PMID:30307764 PMID:34896426

NCBI chr 1:141,310,069...141,884,980
Ensembl chr 1:141,312,368...141,882,274

G

glutamate metabotropic receptor 8

increases expression

fenvalerate results in increased expression of GRM8 mRNA

NCBI chr 4:55,805,762...56,731,690
Ensembl chr 4:55,805,955...56,730,831

G

granulin precursor

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GRN protein

NCBI chr10:87,387,672...87,393,777
Ensembl chr10:87,387,638...87,393,775

G

G1 to S phase transition 2

increases expression

fenvalerate results in increased expression of GSPT2 mRNA

NCBI chr X:59,587,237...59,589,758
Ensembl chr X:59,587,276...59,594,162

G

glutathione-disulfide reductase

decreases activity

fenvalerate metabolite results in decreased activity of GSR protein; fenvalerate results in decreased activity of GSR protein

NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661

G

glutathione S-transferase omega 1

decreases expression

fenvalerate results in decreased expression of GSTO1 protein

NCBI chr 1:246,721,089...246,731,228
Ensembl chr 1:246,721,221...246,731,468

G

glutathione S-transferase pi 1

decreases expression

fenvalerate results in decreased expression of GSTP1 protein

NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226

G

general transcription factor II I

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GTF2I protein

NCBI chr12:22,400,933...22,476,243
Ensembl chr12:22,401,431...22,476,243

G

gametocyte specific factor 1-like

increases expression

fenvalerate results in increased expression of GTSF1L mRNA

NCBI chr 3:151,736,020...151,738,715
Ensembl chr 3:151,735,997...151,736,863

G

guanylate cyclase 1 soluble subunit alpha 1

increases expression

fenvalerate results in increased expression of GUCY1A1 mRNA

NCBI chr 2:167,418,615...167,482,293
Ensembl chr 2:167,418,640...167,481,671

G

guanylate cyclase 1 soluble subunit alpha 2

increases expression

fenvalerate results in increased expression of GUCY1A2 mRNA

NCBI chr 8:500,212...900,201
Ensembl chr 8:500,212...889,203

G

guanylate cyclase 1 soluble subunit beta 2

decreases expression

fenvalerate results in decreased expression of GUCY1B2 mRNA

NCBI chr15:36,589,501...36,669,441
Ensembl chr15:36,598,883...36,669,441

G

guanylate cyclase 2C

increases expression

fenvalerate results in increased expression of GUCY2C mRNA

NCBI chr 4:169,568,505...169,649,092
Ensembl chr 4:169,568,529...169,649,092

G

guanylate cyclase 2E

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GUCY2E protein

NCBI chr10:53,954,918...53,975,576
Ensembl chr10:53,959,010...53,974,067

G

GULP PTB domain containing engulfment adaptor 1

decreases expression

fenvalerate results in decreased expression of GULP1 mRNA

NCBI chr 9:46,622,699...46,899,005
Ensembl chr 9:46,622,669...46,899,005

G

glucuronidase, beta

increases activity

fenvalerate results in increased activity of GUSB protein

NCBI chr12:26,701,188...26,714,718
Ensembl chr12:26,697,951...26,726,905

G

H2A.P histone

increases expression

fenvalerate results in increased expression of H2AP mRNA

NCBI chr X:12,907,962...12,908,516

G

3-hydroxyacyl-CoA dehydratase 4

increases expression

fenvalerate results in increased expression of HACD4 mRNA

NCBI chr 5:102,887,597...102,915,376
Ensembl chr 5:102,887,588...102,915,338

G

hydroxyacyl-CoA dehydrogenase

increases expression

fenvalerate results in increased expression of HADH mRNA

NCBI chr 2:219,787,935...219,830,335
Ensembl chr 2:219,787,927...219,830,353

G

hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha

increases expression
multiple interactions

fenvalerate results in increased expression of HADHA mRNA
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HADHA protein

PMID:30307764 PMID:34896426

NCBI chr 6:26,187,969...26,227,605
Ensembl chr 6:26,187,956...26,227,869

G

hydroxyacyl glutathione hydrolase

decreases expression

fenvalerate results in decreased expression of HAGH protein

NCBI chr10:13,874,883...13,889,527
Ensembl chr10:13,875,241...13,889,504

G

hydroxyacylglutathione hydrolase-like

increases expression

fenvalerate results in increased expression of HAGHL mRNA

NCBI chr10:14,804,957...14,809,495
Ensembl chr10:14,804,997...14,807,665

G

huntingtin-associated protein 1

affects methylation

fenvalerate affects the methylation of HAP1 gene

NCBI chr10:85,277,890...85,286,126
Ensembl chr10:85,277,890...85,286,126

G

hyaluronan and proteoglycan link protein 1

increases expression

fenvalerate results in increased expression of HAPLN1 mRNA

NCBI chr 2:20,631,640...20,696,388
Ensembl chr 2:20,631,640...20,693,777

G

HUWE1 associated protein modifying stress responses

increases expression

fenvalerate results in increased expression of HAPSTR1 mRNA

NCBI chr10:6,746,037...6,774,992
Ensembl chr10:6,746,048...6,774,992

G

hemoglobin subunit beta

decreases expression

fenvalerate results in decreased expression of HBB protein

NCBI chr 1:158,250,421...158,251,832
Ensembl chr 1:158,120,200...158,252,012

G

hemoglobin subunit epsilon 1

increases expression

fenvalerate results in increased expression of HBE1 mRNA

NCBI chr 1:158,282,931...158,458,855
Ensembl chr 1:158,282,936...158,284,391

G

heparin-binding EGF-like growth factor

increases expression

fenvalerate results in increased expression of HBEGF mRNA

NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,105,760...28,116,441

G

hyperpolarization-activated cyclic nucleotide-gated potassium channel 3

increases expression

fenvalerate results in increased expression of HCN3 mRNA

NCBI chr 2:174,551,861...174,567,459
Ensembl chr 2:174,551,680...174,565,966

G

hypocretin receptor 1

increases expression

fenvalerate results in increased expression of HCRTR1 mRNA

NCBI chr 5:142,477,214...142,486,674
Ensembl chr 5:142,477,214...142,486,674

G

histone deacetylase 1

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of HDAC1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HDAC1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of HDAC1 mRNA

PMID:33051911 PMID:33396045 PMID:34896426

NCBI chr 5:141,853,992...141,881,057
Ensembl chr 5:141,853,989...141,881,111

G

histone deacetylase 10

decreases expression
multiple interactions

fenvalerate results in decreased expression of HDAC10 mRNA
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of HDAC10 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HDAC10 mRNA

PMID:30307764 PMID:33051911 PMID:33396045 PMID:34896426

NCBI chr 7:120,199,126...120,205,850
Ensembl chr 7:120,199,129...120,204,228

G

histone deacetylase 4

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of HDAC4 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HDAC4 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in decreased expression of HDAC4 mRNA

PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783

NCBI chr 9:92,503,467...92,750,164
Ensembl chr 9:92,507,611...92,750,164

G

histidine decarboxylase

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HDC mRNA

NCBI chr 3:113,847,256...113,865,334
Ensembl chr 3:113,847,260...113,865,341

G

HDGF like 3

increases expression

fenvalerate results in increased expression of HDGFL3 mRNA

NCBI chr 1:135,822,600...135,876,719
Ensembl chr 1:135,827,549...135,876,719

G

helt bHLH transcription factor

increases expression

fenvalerate results in increased expression of HELT mRNA

NCBI chr16:45,991,227...45,993,045
Ensembl chr16:45,991,227...45,992,960

G

helicase with zinc finger

decreases expression

fenvalerate results in decreased expression of HELZ mRNA

NCBI chr10:92,479,403...92,645,234
Ensembl chr10:92,501,518...92,638,383

G

hypoxia inducible factor 1 subunit alpha

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HIF1A mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of HIF1A mRNA

PMID:33396045 PMID:34896426

NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261

G

hypoxia inducible factor 3 subunit alpha

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HIF3A protein

NCBI chr 1:77,718,110...77,750,448
Ensembl chr 1:77,722,471...77,749,758

G

hexokinase 2

increases expression

fenvalerate results in increased expression of HK2 mRNA

NCBI chr 4:115,234,509...115,283,530
Ensembl chr 4:115,234,509...115,283,530

G

3-hydroxy-3-methylglutaryl-CoA reductase

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of HMGCR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HMGCR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HMGCR mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of HMGCR mRNA

PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783

NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703

G

3-hydroxy-3-methylglutaryl-CoA synthase 1

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of HMGCS1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HMGCS1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HMGCS1 mRNA; [fenvalerate co-treated with Allethrins co-treated with cypermethrin co-treated with decamethrin co-treated with cyhalothrin] results in increased expression of HMGCS1 mRNA

PMID:33051911 PMID:33396045 PMID:34896426 PMID:36053783

NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100

G

HMG-box containing 4

increases expression

fenvalerate results in increased expression of HMGXB4 mRNA

NCBI chr19:13,364,741...13,403,563
Ensembl chr19:13,364,807...13,403,563

G

heme oxygenase 1

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HMOX1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HMOX1 mRNA

PMID:33396045 PMID:34896426

NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079

G

heterogeneous nuclear ribonucleoprotein A2/B1

affects expression

fenvalerate affects the expression of HNRNPA2B1 protein

NCBI chr 4:80,534,659...80,545,297
Ensembl chr 4:80,534,651...80,545,249

G

heterogeneous nuclear ribonucleoprotein D

decreases expression

fenvalerate results in decreased expression of HNRNPD protein

NCBI chr14:9,615,375...9,638,975
Ensembl chr14:9,615,479...9,633,786

G

heterogeneous nuclear ribonucleoprotein K

increases expression

fenvalerate results in increased expression of HNRNPK protein

NCBI chr17:6,262,936...6,275,001
Ensembl chr17:6,262,998...6,274,997

G

homeobox and leucine zipper encoding

increases expression

fenvalerate results in increased expression of HOMEZ mRNA

NCBI chr15:28,321,633...28,339,486
Ensembl chr15:28,320,819...28,339,745

G

homeo box B6

increases expression

fenvalerate results in increased expression of HOXB6 mRNA

NCBI chr10:81,258,726...81,267,458
Ensembl chr10:81,265,056...81,267,449

G

homeobox D8

increases expression

fenvalerate results in increased expression of HOXD8 mRNA

NCBI chr 3:59,607,793...59,610,359
Ensembl chr 3:59,607,996...59,610,361

G

heterochromatin protein 1, binding protein 3

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of HP1BP3 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HP1BP3 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HP1BP3 mRNA

PMID:33051911 PMID:33396045 PMID:34896426

NCBI chr 5:150,435,781...150,463,004
Ensembl chr 5:150,433,740...150,463,000

G

hippocalcin

increases expression

fenvalerate results in increased expression of HPCA mRNA

NCBI chr 5:141,455,616...141,466,252
Ensembl chr 5:141,455,613...141,463,841

G

hippocalcin-like 4

increases expression

fenvalerate results in increased expression of HPCAL4 mRNA

NCBI chr 5:135,454,477...135,466,417
Ensembl chr 5:135,454,540...135,466,416

G

15-hydroxyprostaglandin dehydrogenase

increases expression

fenvalerate results in increased expression of HPGD mRNA

NCBI chr16:33,986,265...34,024,228
Ensembl chr16:33,986,266...34,024,228

G

HPS1, biogenesis of lysosomal organelles complex 3 subunit 1

increases expression

fenvalerate results in increased expression of HPS1 mRNA

NCBI chr 1:241,551,180...241,577,292
Ensembl chr 1:241,551,175...241,577,268

G

hemopexin

decreases expression

fenvalerate results in decreased expression of HPX protein

NCBI chr 1:159,932,819...159,940,327
Ensembl chr 1:159,932,755...159,940,328

G

histamine receptor H 2

increases expression

fenvalerate results in increased expression of HRH2 mRNA

NCBI chr17:10,366,004...10,407,791
Ensembl chr17:10,368,298...10,407,631

G

histamine receptor H4

increases expression

fenvalerate results in increased expression of HRH4 mRNA

NCBI chr18:4,166,270...4,182,426
Ensembl chr18:4,166,270...4,246,345

G

hydroxysteroid (17-beta) dehydrogenase 1

decreases expression
affects expression
increases expression

fenvalerate results in decreased expression of HSD17B1 mRNA
fenvalerate affects the expression of HSD17B1 protein
fenvalerate results in increased expression of HSD17B1 mRNA

PMID:16001830 PMID:21232584 PMID:30307764

NCBI chr10:86,009,728...86,011,928
Ensembl chr10:86,009,728...86,011,927

G

hydroxysteroid (17-beta) dehydrogenase 14

increases expression

fenvalerate results in increased expression of HSD17B14 mRNA

NCBI chr 1:96,029,224...96,039,577
Ensembl chr 1:96,029,284...96,039,883

G

hydroxysteroid (17-beta) dehydrogenase 2

decreases expression

fenvalerate results in decreased expression of HSD17B2 mRNA

NCBI chr19:45,753,576...45,825,203
Ensembl chr19:45,753,574...45,825,202

G

hydroxysteroid (17-beta) dehydrogenase 3

increases expression
multiple interactions

fenvalerate results in increased expression of HSD17B3 mRNA
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of HSD17B3 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HSD17B3 mRNA

PMID:30307764 PMID:33051911 PMID:33396045 PMID:34896426

NCBI chr17:1,027,229...1,058,554
Ensembl chr17:1,027,229...1,058,554

G

hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of HSD3B1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HSD3B1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of HSD3B1 mRNA

PMID:33051911 PMID:33396045 PMID:34896426

NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999

G

heat shock transcription factor 2

multiple interactions

[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of HSF2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HSF2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HSF2 mRNA

PMID:33051911 PMID:33396045 PMID:34896426

NCBI chr20:36,819,864...36,847,490
Ensembl chr20:36,819,864...36,850,174

G

heat shock transcription factor 2 binding protein

increases expression

fenvalerate results in increased expression of HSF2BP mRNA

NCBI chr20:10,035,562...10,123,059
Ensembl chr20:10,035,562...10,121,242

G

heat shock protein 90 alpha family class A member 1

decreases expression

fenvalerate results in decreased expression of HSP90AA1 protein

NCBI chr 6:129,702,376...129,707,907
Ensembl chr 6:129,702,383...129,707,268

G

heat shock protein 90 beta family member 1

decreases expression

fenvalerate results in decreased expression of HSP90B1 protein

NCBI chr 7:21,110,431...21,124,762
Ensembl chr 7:21,110,457...21,124,788

G

heat shock protein family A (Hsp70) member 12B

increases expression

fenvalerate results in increased expression of HSPA12B mRNA

NCBI chr 3:118,346,372...118,364,374
Ensembl chr 3:118,346,354...118,364,737

G

heat shock protein family A (Hsp70) member 2

increases expression

fenvalerate results in increased expression of HSPA2 mRNA

NCBI chr 6:95,128,504...95,131,281
Ensembl chr 6:95,128,350...95,131,287

G

heat shock protein family A (Hsp70) member 4 like

decreases expression

fenvalerate results in decreased expression of HSPA4L protein

NCBI chr 2:123,740,384...123,793,088
Ensembl chr 2:123,740,384...123,793,084

G

heat shock protein family A (Hsp70) member 5

affects expression

fenvalerate affects the expression of HSPA5 protein

NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891

G

heat shock protein family A (Hsp70) member 8

affects expression

fenvalerate affects the expression of HSPA8 protein

NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259

G

heat shock protein family B (small) member 7

increases expression

fenvalerate results in increased expression of HSPB7 mRNA

NCBI chr 5:153,727,782...153,731,268
Ensembl chr 5:153,727,588...153,731,266

G

5-hydroxytryptamine receptor 1F

increases expression

fenvalerate results in increased expression of HTR1F mRNA

NCBI chr11:2,642,751...2,644,150
Ensembl chr11:2,642,751...2,644,150

G

5-hydroxytryptamine receptor 2C

increases expression

fenvalerate results in increased expression of HTR2C mRNA

NCBI chr X:110,640,777...110,870,288
Ensembl chr X:110,641,153...110,870,287

G

5-hydroxytryptamine receptor 6

increases expression

fenvalerate results in increased expression of HTR6 mRNA

NCBI chr 5:151,295,269...151,312,853
Ensembl chr 5:151,296,662...151,311,912

G

HtrA serine peptidase 4

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HTRA4 protein

NCBI chr16:67,001,605...67,015,074
Ensembl chr16:67,001,605...67,015,074

G

hyccin PI4KA lipid kinase complex subunit 2

increases expression

fenvalerate results in increased expression of HYCC2 mRNA

NCBI chr 9:60,056,883...60,129,176
Ensembl chr 9:60,056,890...60,093,007

G

hypoxia up-regulated 1

increases expression

fenvalerate results in increased expression of HYOU1 mRNA

NCBI chr 8:44,706,073...44,718,189
Ensembl chr 8:44,706,263...44,718,186

G

islet amyloid polypeptide

increases expression

fenvalerate results in increased expression of IAPP mRNA

NCBI chr 4:175,237,107...175,244,373
Ensembl chr 4:175,237,115...175,242,920

G

islet cell autoantigen 1-like

increases expression

fenvalerate results in increased expression of ICA1L mRNA

NCBI chr 9:61,410,959...61,469,884
Ensembl chr 9:61,412,091...61,470,134

G

intercellular adhesion molecule 2

increases expression

fenvalerate results in increased expression of ICAM2 mRNA

NCBI chr10:91,308,608...91,319,536
Ensembl chr10:91,308,538...91,315,293

G

inhibitor of DNA binding 2

increases expression

fenvalerate results in increased expression of ID2 mRNA

NCBI chr 6:41,740,556...41,742,393
Ensembl chr 6:41,728,946...41,744,400

G

isocitrate dehydrogenase (NAD(+)) 3 catalytic subunit alpha

increases expression

fenvalerate results in increased expression of IDH3A protein

NCBI chr 8:54,971,694...54,991,085
Ensembl chr 8:54,971,740...54,991,084

G

isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit beta

increases expression

fenvalerate results in increased expression of IDH3B protein

NCBI chr 3:117,481,845...117,486,909
Ensembl chr 3:117,481,845...117,486,982

G

intraflagellar transport 81

increases expression

fenvalerate results in increased expression of IFT81 mRNA

NCBI chr12:33,957,744...34,037,164
Ensembl chr12:33,957,806...34,037,057

G

insulin-like growth factor 1

decreases expression
decreases secretion

fenvalerate results in decreased expression of IGF1 mRNA
fenvalerate results in decreased secretion of IGF1 protein

NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296

G

insulin-like growth factor 1 receptor

increases expression

fenvalerate results in increased expression of IGF1R mRNA

NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777

G

insulin-like growth factor 2

decreases expression
increases expression

fenvalerate results in decreased expression of IGF2 mRNA
fenvalerate results in increased expression of IGF2 mRNA

PMID:28369636 PMID:30307764

NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018

G

insulin-like growth factor 2 mRNA binding protein 1

increases expression

fenvalerate results in increased expression of IGF2BP1 mRNA

NCBI chr10:80,908,300...80,951,097
Ensembl chr10:80,908,076...80,951,129

G

insulin-like growth factor binding protein-like 1

increases expression

fenvalerate results in increased expression of IGFBPL1 mRNA

NCBI chr 5:60,076,428...60,091,833
Ensembl chr 5:60,076,429...60,091,833

G

immunoglobulin superfamily, member 9

multiple interactions

[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of IGSF9 protein

NCBI chr13:84,948,643...84,965,616
Ensembl chr13:84,948,619...84,965,607

G

IKBKB interacting protein

decreases expression

fenvalerate results in decreased expression of IKBIP mRNA

NCBI chr 7:25,579,865...25,598,548
Ensembl chr 7:25,579,832...25,605,162

G

interleukin 12B

increases expression